Lithium Exploration (LEXG) 10-Q 4 Mar 16 2016 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Sep. 30, 2015	Mar. 01, 2016
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Trading Symbol	lexg
Entity Registrant Name	Lithium Exploration Group, Inc.
Entity Central Index Key	1,375,576
Current Fiscal Year End Date	--06-30
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		11,107,825
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well Known Seasoned Issuer	No
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q1

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2015	Jun. 30, 2015
Current
Cash and cash equivalents	$ 34,577	$ 64,098
Receivable	0	13,421
Loan receivable	0	20,000
Prepaid expenses	2,788	2,788
Current assets held for sale	46,499	14,713
Total current assets	83,864	115,020
Total Assets	83,864	115,020
Current
Accounts payable and accrued liabilities	104,916	65,962
Derivative liability - convertible promissory notes	9,449,354	1,646,448
Derivative liability - warrants	995,411	143,375
Due to related party	115,000	115,000
Convertible promissory notes - net of unamortized discount	597,204	533,994
Accrued interest - convertible promissory notes	83,003	60,022
Current liabilities held for sale	6,236	6,696
Total Current Liabilities	11,351,124	2,571,497
DEFICIT Lithium Explorations Group, Inc. Stockholders' Deficit
Capital stock Authorized: 100,000,000 preferred shares, $0.001 par value Issued and outstanding: Nil preferred shares (June 30, 2015 - Nil)	0	0
Capital stock Authorized:10,000,000,000 (June 30, 2015 - 2,000,000,000) common shares, $0.001 par value Issued and outstanding: 11,107,825 common shares (June 30, 2015 - 7,574,353)	11,107	7,575
Additional paid-in capital	47,751,245	47,383,231
Accumulated other comprehensive loss	(39,074)	(29,486)
Accumulated deficit	(58,650,592)	(49,504,347)
Total Lithium Exploration Group, Inc. Stockholders' Deficit	(10,927,314)	(2,143,027)
Non-controlling interest	(339,946)	(313,450)
Total Deficit	(11,267,260)	(2,456,477)
Total Liabilities and Stockholders' Deficit	$ 83,864	$ 115,020

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2015	Jun. 30, 2015
Preferred Stock, Shares Authorized	100,000,000	100,000,000
Preferred Stock, Par Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Shares Authorized	10,000,000,000	2,000,000,000
Common Stock, Par Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares, Issued	11,107,825	7,574,353
Common Stock, Shares, Outstanding	11,107,825	7,574,353

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations And Comprehensive Income (Loss) - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Revenue	$ 0	$ 0
Operating Expenses:
Mining	5,000	15,000
Selling, general and administrative	141,809	337,991
Total operating expenses	146,809	352,991
Loss from operations	(146,809)	(352,991)
Other income (expenses)
Interest expense	(346,779)	(724,071)
Gain (loss) on change in the fair value of derivative liability	(8,441,773)	3,223,429
Amortization of Debt Discount (Premium)	(170,943)	(709,644)
Bad debt write-off	(20,000)	0
Gain on disposal of business asset	7,637	0
Equity in income of investment held for sale	0	48,423
(Loss) income before income taxes	(9,118,667)	1,485,146
Provision for Income Taxes	0	0
(Loss) income from continuing operations	(9,118,667)	1,485,146
(Loss) from discontinued operations	(54,074)	(148,571)
Net (loss) income	(9,172,741)	1,336,575
Less: Net (loss) income attributable to the non-controlling interest	(26,496)	(72,800)
Net (loss) income attributable to Lithium Exploration Group, Inc. Common shareholders	$ (9,146,245)	$ 1,409,375
Basic and Diluted (loss) income per Common Share	$ (4)	$ 22.24
Basic and Diluted Weighted Average Number of Common Shares Outstanding	2,286,192	63,360
Comprehensive (loss) income :
Net (loss) income	$ (9,172,741)	$ 1,336,575
Foreign currency translation adjustment	9,588	(1,864)
Comprehensive (loss) income	(9,163,153)	1,334,711
Comprehensive income (loss) attributable to non-controlling interest	(26,496)	(72,800)
Comprehensive (loss) income attributable to Lithium Exploration Group, Inc.	$ (9,136,657)	$ 1,407,511

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Changes in Stockholders Deficit - USD ($)	Preferred Shares [Member]	Common Shares [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]	Non-controlling interest [Member]	Total
Beginning Balance at Jun. 30, 2014	$ 0	$ 48	$ 39,111,899	$ (5,769)	$ (46,987,979)	$ (101,400)	$ (7,983,201)
Beginning Balance (Shares) at Jun. 30, 2014		47,990
Common shares issued for consulting fees		$ 3	118,987				118,990
Common shares issued for consulting fees (Shares)		2,594
Common shares issued for investor relations		$ 1	67,999				68,000
Common shares issued for investor relations (Shares)		500
Common shares issued for debt conversion		$ 7,421	2,179,398				2,186,819
Common shares issued for debt conversion (Shares)		7,421,245
Common shares issued for the reclassification of derivative liability on convertible notes			3,174,990				3,174,990
Common shares issued to depository trust			38				38
Common shares issued to depository trust (Shares)		20
Common shares issued for exercise of warrants		$ 102	2,729,920				2,730,022
Common shares issued for exercise of warrants (Shares)		102,004
Foreign exchange translation				(23,717)			(23,717)
Net loss for the year					(2,516,368)	(212,050)	(2,728,418)
Ending Balance at Jun. 30, 2015	$ 0	$ 7,575	47,383,231	(29,486)	(49,504,347)	(313,450)	(2,456,477)
Ending Balance (Shares) at Jun. 30, 2015		7,574,353
Common shares issued for debt conversion		$ 3,532	106,971				110,503
Common shares issued for debt conversion (Shares)		3,533,472
Common shares issued for the reclassification of derivative liability on convertible notes			200,856				200,856
Disposal of business operations			60,187				60,187
Foreign exchange translation				(9,588)			(9,588)
Net loss for the year					(9,146,245)	(26,496)	(9,172,741)
Ending Balance at Sep. 30, 2015		$ 11,107	$ 47,751,245	$ (39,074)	$ (58,650,592)	$ (339,946)	$ (11,267,260)
Ending Balance (Shares) at Sep. 30, 2015		11,107,825

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash Flows from Operating Activities
Net loss from continuing operations	$ (9,118,667)	$ 1,485,146
Loss from discontinued operations	(54,074)	(148,571)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity in income of investment held for sale	0	(48,423)
Common shares issued for consulting fees	0	87,000
Non-cash Interest expense	323,793	640,006
Investment impairment	60,178	0
Bad debt written-off	20,000	0
Common shares issued for interest expenses	0	31,642
(Gain) loss on change in the fair value of derivative liability	8,441,773	(3,223,429)
Amortization of discount	170,943	709,644
Changes in operating assets and liabilities:
Receivable, net	13,421	0
Prepaid expenses	0	16,610
Accrued interest	22,986	52,423
Accounts payable and accrued liabilities	38,961	39,281
Net cash used in operating activities from continuing operations	(80,686)	(358,671)
Net cash used in operating activities from discontinued operations	(32,247)	65,941
Net cash used in operating activities	(112,933)	(292,730)
Cash Flows from Financing Activities
Proceed from issuance of convertible promissory notes	93,000	400,000
Net cash provided by financing activities	93,000	400,000
Effect of foreign exchange	(9,588)	(1,864)
Increase (decrease) in cash and cash equivalents	(29,521)	105,406
Cash and cash equivalents - beginning of period	64,098	57,632
Cash and cash equivalents - end of period	34,577	163,038
Cash paid during the period for:
Interest	0	0
Income taxes	0	0
Non-cash investing and financing activities:
Common stock issued for debt conversion	110,503	523,664
Common stock issued on cashless exercise of warrants	0	2,371,934
Derivative liability re-classed to additional paid in capital	200,856	919,506
Debt discount on convertible note and warrants	0	367,333
Initial derivative liability on note issuance	$ 414,024	$ 1,007,232

Organization

Organization	3 Months Ended
	Sep. 30, 2015
Organization [Text Block]	1. Organization Lithium Exploration Group, Inc. (formerly Mariposa Resources, Ltd.) (the “Company”) was incorporated on May 31, 2006 in the State of Nevada, U.S.A. It is based in Phoenix, Arizona, USA. The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America, and the Company’s fiscal year end is June 30. Effective November 30, 2010, the Company changed its name to “Lithium Exploration Group, Inc.,” by way of a merger with its wholly-owned subsidiary Lithium Exploration Group, Inc., which was formed solely for the change of name. A wholly owned subsidiary, 1617437 Alberta Ltd. was incorporated in the province of Alberta, Canada on July 8, 2011. Effective October 2, 2013, the subsidiary changed its name to Alta Disposal Ltd. On October 18, 2013, the Company acquired 51% interest in Alta Disposal Morinville Ltd. (formerly Blue Tap Resources Ltd.). Effective September 4, 2015, the Company entered into an Asset Purchase Agreement with Cancen Oil Canada whereby the Company agrees to sell all right, title and interest of Alta Disposal Morinville Ltd. assets for total purchase price of CAD$10,000 approximately USD$7,466. On March 1, 2014, the Company through its 100% subsidiary Alta Disposal Ltd. acquired 50% interest in Tero Oilfield Services Ltd. (the “Tero”) On May 1, 2015, the Company entered into a Share Purchase Agreement with an individual and disposed its 50% interest in Tero. The Company is engaged principally in the acquisition, exploration, and development of resource properties. Prior to June 25, 2009, the Company had the right to conduct exploration work on 20 mineral mining claims in Esmeralda County, Nevada, U.S.A. On July 31, 2009, the Company acquired an option to enter into a joint venture for the management and ownership of the Jack Creek Project, a mining project located in Elko County, Nevada. On September 25, 2009, the joint venture was terminated and the Company entered into an agreement with Beeston Enterprises Ltd., under which the Company was granted an option to acquire an undivided 50% interest in eight mineral claims located in the Clinton Mining District of British Columbia, Canada. On December 16, 2010, the Company entered into an Assignment Agreement to acquire an undivided 100% right, title and interest in and to certain mineral permits located in the Province of Alberta, Canada (see Note 5). On November 8, 2011, the Company entered into a letter agreement with Glottech-USA. Pursuant to the terms of the agreement, the Company was granted an exclusive license to use and distribute the technology within the Swan Hills region of Alberta as well as a non-exclusive right to distribute the technology within Canada.

Significant Accounting Policies

Significant Accounting Policies	3 Months Ended
	Sep. 30, 2015
Significant Accounting Policies [Text Block]	2. Significant Accounting Policies Basis of presentation and consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. These interim financial statements as of and for the three months ended September 30, 2015 and 2014 are unaudited; however, in the opinion of management, such statements include all adjustments (consisting of normal recurring accruals) necessary to present fairly the financial position, results of operations and cash flows of the Company for the periods presented. The results for the three months ended September 30, 2015 are not necessarily indicative of the results to be expected for the year ending June 30, 2016 or for any future period. All references to September 30, 2015 and 2014 in these footnotes are unaudited. These unaudited condensed consolidated financial statements should be read in conjunction with our audited financial statements and the notes thereto for the year ended June 30, 2015, included in the Company’s annual report on Form 10-K filed with the SEC on December 3, 2015. The condensed balance sheet as of June 30, 2015 has been restated during the period ending September 30, 2015, and do not include all disclosures required by the accounting principles generally accepted in the United States of America. Principal of Consolidation The consolidated financial statements include the accounts of the Company, its wholly-owned subsidiary Alta Disposal Ltd. and its 51% owned subsidiary Alta Disposal Morinville Ltd. (formerly Bluetap Resources Ltd.). Intercompany accounts and transactions have been eliminated in consolidation in conformity with the applicable accounting framework. Use of Estimates The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s periodic filings with the Securities and Exchange Commission include, where applicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and future operations of the Company. Significant estimates that may materially change in the near term include the valuation of derivative liabilities and the underlying warrants, as well as fair value of investments. Cash and Cash Equivalents Cash and cash equivalents include cash in banks, money market funds, and certificates of term deposits with original maturities of less than three months, which are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss in value. The Company had $34,577 and $64,099 in cash and cash equivalents at September 30, 2015 and June 30, 2015, respectively. Concentration of Risk The Company maintains cash balances at a financial institution which, from time to time, may exceed Federal Deposit Insurance Corporation insured limits for banks located in the US. As of September 30, 2015 and June 30, 2015, the Company had $Nil and $Nil, respectively, in deposits in excess of federally insured limits in its US bank. The Company has not experienced any losses with regard to its bank accounts and believes it is not exposed to any risk of loss on its cash in bank accounts. Prepaid expenses Prepaid expenses consist of security deposit for office lease which will be expensed or refunded at the end of the lease period. Start-Up Costs In accordance with FASC 720-15-20 “ Start-Up Costs,” Mineral Acquisition and Exploration Costs The Company has been in the exploration stage since its formation on May 31, 2006. It is primarily engaged in the acquisition, exploration, and development of mining properties. Mineral property acquisition and exploration costs are expensed as incurred. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs incurred to develop such property are capitalized. Such costs will be amortized using the units-of-production method over the estimated life of the probable reserves. Concentrations of Credit Risk The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited. Net Income or (Loss) per Share of Common Stock The Company has adopted FASC Topic No. 260, “ Earnings Per Share Potentially dilutive securities are not presented in the computation of EPS since their effects are anti-dilutive. Foreign Currency Translations The Company’s functional and reporting currency is the US dollar. All transactions initiated in other currencies are translated into US dollars using the exchange rate prevailing on the date of transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the US dollar at the rate of exchange in effect at the balance sheet date. Unrealized exchange gains and losses arising from such transactions are deferred until realization and are included as a separate component of stockholders’ equity (deficit) as a component of comprehensive income or loss. Upon realization, the amount deferred is recognized in income in the period when it is realized. Translation of Foreign Operations The financial results and position of foreign operations whose functional currency is different from the Company’s presentation currency are translated as follows: Exchange differences arising on translation of foreign operations are transferred directly to the Company’s accumulated other comprehensive loss in the consolidated balance sheets. Transaction gains and losses arising from exchange rate fluctuation on transactions denominated in a currency other than the functional currency are included in the consolidated statements of operations. The relevant translation rates are as follows: For the period ending September 30, 2015 closing rate at 0.7466 CDN$: US$, average rate at 0.7637 CDN$: US$ and for the year ended June 30, 2015 closing rate at 0.8017 CDN$: US$, average rate at 0.8518 CDN$: US$. Comprehensive Income (Loss) FASC Topic No. 220, “ Comprehensive Income,” Risks and Uncertainties The Company operates in the resource exploration industry that is subject to significant risks and uncertainties, including financial, operational, technological, and other risks associated with operating a resource exploration business, including the potential risk of business failure. Environmental Expenditures The operations of the Company have been, and may in the future be, affected from time to time in varying degree by changes in environmental regulations, including those for future reclamation and site restoration costs. Both the likelihood of new regulations and their overall effect upon the Company vary greatly and are not predictable. The Company's policy is to meet or, if possible, surpass standards set by relevant legislation by application of technically proven and economically feasible measures. Environmental expenditures that relate to ongoing environmental and reclamation programs are charged against earnings as incurred or capitalized and amortized depending on their future economic benefits. All of these types of expenditures incurred since inception have been charged against earnings due to the uncertainty of their future recoverability. Estimated future reclamation and site restoration costs, when the ultimate liability is reasonably determinable, are charged against earnings over the estimated remaining life of the related business operation, net of expected recoveries. Warrants The Company accounts for currently outstanding detachable warrants to purchase common stock as derivative liabilities as they are freestanding derivative financial instruments. The warrants are recorded as derivative liabilities at fair value, estimated using a Black-Scholes option pricing model, and marked to market at each balance sheet date, with changes in the fair value of the derivative liabilities recorded in the condensed consolidated statements of operations and comprehensive Income (Loss). Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815 “Derivatives and Hedging”. It provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of notes redemption. Fair Value of Financial Instruments ASC 820, “Fair Value Measurements and Disclosures” Level 1 - Quoted prices in active markets for identical assets or liabilities; Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing. The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, prepaid expenses, deposit, accounts payable and accrued liabilities, and due to a related party approximate their fair values because of the short maturity of these instruments. The Company’s Level 3 financial liabilities consist of the liability of the Company’s secured convertible promissory notes and debentures issued to investors, and the derivative warrants issued in connection with these convertible promissory notes and debentures. There is no current market for these securities such that the determination of fair value requires significant judgment or estimation. The Company used a fair value model which incorporates transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date. Revenue Recognition The Company has generated little revenues to date. It is the Company’s policy that revenue from product sales or services will be recognized in accordance with ASC 605 “Revenue Recognition”. Four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company will defer any revenue for which the product/services was not delivered or is subject to refund until such time that the Company and the customer jointly determine that the product/service has been delivered or no refund will be required. Sales comprise the fair value of the consideration received or receivable for the sale of goods and rendering of services in the ordinary course of the Company’s activities. Sales are presented, net of tax, rebates and discounts, and after eliminating intercompany sales. The Company recognizes revenue when the amount of revenue and related cost can be reliably measured and it is probable that the collectability of the related receivables is reasonably assured. Income Taxes The Company recognizes the tax effects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reported for tax purposes. Deferred taxes are provided in the financial statements under FASC 740-20-20 to give effect to the resulting temporary differences which may arise from differences in the bases of fixed assets, depreciation methods, allowances, and start-up costs based on the income taxes expected to be payable in future years. Receivables Trade and other receivables are customer obligations due under normal trade terms and are recorded at face value less any provisions for uncollectible amounts considered necessary. The Company includes any balances that are determined to be uncollectible in its overall allowance for doubtful accounts. The Company recorded $Nil (June 30, 2015 - $18,984) in allowance for doubtful accounts. Recent Accounting Pronouncements In August 2015, the FASB issued ASU 2015-15 “Interest – Imputation of Interest (Subtopic 835-30) – Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements (Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting).” The guidance issued previously in ASU 2015-03 did not address presentation or subsequent measurement of debt issuance costs related to line-of-credit arrangements. Given the absence of authoritative guidance within ASU 2015-03, the SEC staff stated that they would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments. In September 2015, the FASB issued ASU 2015-16 an update to its guidance on business combinations. The new guidance requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the measurement amounts are determined. The new guidance also requires that the acquirer records, in the same period’s financial statements, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed as of the acquisition date. The new guidance also requires an entity to present separately on the face of the income statement, or disclose in the notes, the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments. FASB Statements: In June 2009 the FASB established the Accounting Standards Codification ("Codification" or "ASC") as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States ("GAAP"). Rules and interpretive releases of the Securities and Exchange Commission ("SEC") issued under authority of federal securities laws are also sources of GAAP for SEC registrants. Existing GAAP was not intended to be changed as a result of the Codification, and accordingly the change did not impact our financial statements. The ASC does change the way the guidance is organized and presented. Accounting Standards Updates ("ASUs") through ASU No. 2014-08 which contain technical corrections to existing guidance or affect guidance to specialized industries or entities were recently issued. These updates have no current applicability to the Company or their effect on the financial statements would not have been significant.

Capital Stock

Capital Stock	3 Months Ended
	Sep. 30, 2015
Capital Stock [Text Block]	3. Capital Stock On January 19, 2015, the Company's board of directors consented to effect a reverse stock split of the Company’s issued and outstanding shares of common stock on a basis of 20 old shares of common stock for one 1 new share of common stock. The reverse stock split was reviewed and approved for filing by the FNRA effective February 25, 2015. On July 13, 2015, the Company's board of directors consented to effect a reverse stock split of the Company’s issued and outstanding shares of common stock on a basis of 200 old shares of common stock for one 1 new share of common stock. The reverse stock split was reviewed and approved for filing by the FNRA effective September 30, 2015. Upon effect of the reverse stock split the issued and outstanding shares pre-split as at September 30, 2015 were 2,221,565,094 and the post-split were 11,107,825. The Company’s authorized capital will not be affected by the reverse stock split. The split is reflected retrospectively in the accompanying financial statements. Authorized Stock At inception, the Company authorized 100,000,000 common shares and 100,000,000 preferred shares, both with a par value of $0.001 per share. Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought. On April 8, 2009, the Company increased the number of authorized shares to 600,000,000 shares, of which 500,000,000 shares are designated as common stock par value $0.001 per share, and 100,000,000 shares are designated as preferred stock, par value $0.001 per share. On October 25, 2012, the Company designated 20,000,000 series A convertible preferred stock with a par value of $0.001 per share and stated value of $100 per share. The designated preferred stock is convertible at the option of the holder, at any time beginning one year from the date such shares are issued, into common stock of the Company with a par value of $0.001. All shares of common stock of the Company, shall be of junior rank to all series A preferred stock in respect to the preferences as to distributions and payments upon the liquidation, dissolution and winding up of the Company. All other shares of preferred stock shall be of junior rank to all series A preferred shares in respect to the preferences as to distributions and payments upon the liquidation, dissolution and winding up of the Company. On January 3, 2014, the Company designated 2,000,000 series B convertible preferred stock with a par value $0.001 per share, issuable only in consideration of the extinguishment of existing debt convertible in to the Company’s common stock with a par value of $0.001. The designated preferred stock shall be issued on the basis of 1 preferred stock for each $1 of convertible debt. The series B convertible preferred stock shall be subordinate to and rank junior to all indebtedness of the Company now or hereafter outstanding. On October 17, 2014, the Company amended its Articles of Incorporation, which amendment was filed with the Nevada Secretary of State on October 17, 2014, to increase the authorized capital of its common shares from 500,000,000 common shares, par value $0.001 to 2,000,000,000 common shares, par value $0.001. The Company's authorized capital consists of 2,000,000,000 common shares and 100,000,000 preferred shares, all with a par value of $0.001. Effective June 22, 2015, the Company designated 50,000,000 of its 100,000,000 authorized shares of preferred stock as series A preferred stock. The series A preferred stock, par value $0.001, will rank senior to the Company’s common stock, carrying general voting rights with the common stock at the rate of 62 votes per share. The series A preferred stock will be deemed cancelled within 1 year of issuance and are not entitled to share in dividends or other distributions. So long as any shares of series A preferred stock are outstanding, the affirmative vote of not less than 75% of those outstanding shares of series A preferred stock will be required for any change to the Company’s Articles of Incorporation. Effective September 9, 2015, the Company increase the authorized capital of its common shares from 2,000,000,000 common shares, par value $0.001 to 10,000,000,000 common shares, par value $0.001. Share Issuances Common Stock Issuance For the period ended September 30, 2015: On July 8, 2015, the Company issued 125,000 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On July 10, 2015, the Company issued 201,465 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On July 21, 2015, the Company issued 250,000 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On July 22, 2015, the Company issued 100,000 common shares at a deemed price of $0.05 per share for promissory note conversion (Note 6). On July 29, 2015, the Company issued 298,269 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On August 17, 2015, the Company issued 250,000 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On September 11, 2015, the Company issued 80,801 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On September 11, 2015, the Company issued 434,084 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6). On September 15, 2015, the Company issued 438,000 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6). On September 18, 2015, the Company issued 486,623 common shares at a deemed price of $0.02 per share for promissory note conversion (Note 6). On September 18, 2015, the Company issued 475,000 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6). On September 18, 2015, the Company issued 394,231 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6). Issuances of Preferred Shares On June 22, 2015, the Company designated 50,000,000 of its 100,000,000 authorized shares of Preferred Stock as Series “A” Preferred Stock. The Series “A’ Preferred Stock, par value $0.001, ranks senior to the common stock and carries general voting rights with the common stock at the rate of 62 votes per share. The Series “A” Preferred Stock will be deemed cancelled within 1 year of issuance and is not entitled to share in dividends or other distributions. So long as any shares of Series “A” Preferred Stock are outstanding, the affirmative vote of not less than 75% of those outstanding shares of Series “A” Preferred Stock will be required for any change to articles of incorporation. On July 6, 2015, the Company issued 130,000 Series “A” preferred shares in consideration of the release and discharge of a first ranking general security interest over all current and future assets of Alta Disposal Ltd. that was granted to secure to the promissory note entered into on July 22, 2014. These shares were issued at par value of $0.001. These shares were subsequently cancelled on December 5, 2015 therefore the net impact on share capital is nil.

Provision For Income Taxes

Provision For Income Taxes	3 Months Ended
	Sep. 30, 2015
Provision For Income Taxes [Text Block]	4. Provision for Income Taxes The Company recognizes the tax effects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reported for tax purposes. Deferred taxes are provided in the financial statements under FASC 740-20-20 to give effect to the resulting temporary differences which may arise from differences in the bases of fixed assets, depreciation methods, allowances, and start-up costs based on the income taxes expected to be payable in future years. Exploration stage deferred tax assets arising as a result of net operating loss carryforwards have been offset completely by a valuation allowance due to the uncertainty of their utilization in future periods. Operating loss carryforwards generated during the period from May 31, 2006 (date of inception) through September 30, 2015 of approximately $12,974,856 will begin to expire in 2026. Accordingly, deferred tax assets were offset by the valuation allowance that increased by approximately $151,535 and $1,130,089 during the periods ended September 30, 2015 and June 30, 2015 respectively. The Company follows the provisions of uncertain tax positions as addressed in FASC 740-10-65-1. The Company recognized approximately no increase in the liability for unrecognized tax benefits. The Company has no tax position at September 30, 2015 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. No such interest or penalties were recognized during the periods presented. The Company had no accruals for interest and penalties at September 30, 2015. The Company’s utilization of any net operating loss carry forward may be unlikely as a result of its intended exploration stage activities. The tax years for June 30, 2015, June 30, 2014, June 30, 2013 and June 30, 2012 are still open for examination by the Internal Revenue Service (IRS). For the three months ended September 30, 2015 Amount Tax Effect ( 35%) Net loss $ 9,118,667 $ 3,191,533 Shares issued for consulting fees, mining expenses, investor relation and director fees Interest Expense (346,779 ) (121,373 ) Loss on derivative liability (8,441,773 ) (2,954,621 ) Amortization of discount (170,943 ) (59,830 ) Impairment (7,637 ) (2,673 ) Total 151,535 53,037 Valuation allowance (151,535 ) (53,037 ) Net deferred tax asset (liability) $ - $ - For the three months ended September 30, 2014 Amount Tax Effect ( 35%) Net loss $ (1,336,574 ) $ (467,801 ) Shares issued for consulting fees, mining expenses, investor relation and director fees 87,000 30,450 Shares issued for interest expenses 31,642 11,075 Amortization of discount 709,644 248,376 Interest Expense 724,071 253,425 Gain on derivative liability (3,223,429 ) (1,128,200 ) Total 3,439,212 (1,052,676 ) Valuation allowance $ (3,439,212 ) $ 1,052,676 Net deferred tax asset (liability) $ - $ -

Mineral Property Costs

Mineral Property Costs	3 Months Ended
	Sep. 30, 2015
Mineral Property Costs [Text Block]	5. Mineral Property Costs Mineral Permit (Assignment Agreement with Lithium Exploration VIII Ltd.) On December 16, 2010, the Company entered into an Assignment Agreement to acquire the following: a. ) An undivided 100% right, title and interest in and to certain mineral permits located in the Province of Alberta, Canada. b. ) All of the assignor’s right, title and interest in and to the Option Agreement. In consideration for the Assignment, the Company agreed to pay US$90,000 by way of cash or stock of equal value (consisting of amounts previously paid by the Assignor pursuant to the Option Agreement). The full $90,000 (consisting of option payments ‘i’ and ‘v’ below) was expensed and included in the December 31, 2011 accounts payable balance. The Option shall be in good standing and exercisable by the Company by paying the following amounts on or before the dates specified in the following schedule: i. ) CDN $40,000 (paid) upon execution of the agreement; ii. ) CDN $60,000 (paid) on or before January 1, 2012; iii. ) CDN $100,000 on or before January 1, 2013 (amended and paid); iv. ) CDN $300,000 on or before January 1, 2014 (not paid); and v. ) Paying all such property payments as may be required to maintain the mineral permits in good standing. The Optionee shall provide a refundable amount of CDN$50,000 (paid) to the Optionor by November 2, 2010, which shall be applied by the Optionor towards work assessment expenses acceptable to the Government of Alberta, with any unused portion to be applied against payments required to maintain the permits underlying the property in good standing. On December 31, 2012, the Company entered into an agreement to amend the original payment requirement of CDN$100,000 due on January 1, 2013 to the following payments: CDN $20,000 (paid) cash payment due on January 1, 2013 and CDN $80,000 by a 15% one year promissory note starting January 1, 2013. The promissory note is interest free until March 31, 2013. After then, interest will accrue on the principal balance then in arrears at the rate of 15% per annum. No payments shall be payable until December 31, 2013. At any time, the Optionor may elect to convert the remaining balance of CDN $80,000 plus accrued interest into common shares of the Company at 75% of the closing market price of the Company’s common shares on the election day. The full CDN$100,000 (US$95,008) (consisting of cash payment of CDN$20,000 (US$19,164) and note payable of CDN$80,000 (US$75,844) was expensed. The note is subject to be measured at its fair value in accordance with ASC 480-10-25-14. The fair value at issuance was CDN$106,667 (US$101,125) as of June 30, 2013. An additional $26,667 was charged to mining expense during the year June 30, 2013. An interest expense of CDN$3,058 (US$2,899) was accrued as at June 30, 2013. On July 3, 2013, the Optionor elected to convert the promissory note of CDN $80,000 (US$75,844) plus accrued interest of CDN$3,058 (US$2,899) for the total amount of CDN $83,058 (US$78,743) into 239 common shares of the Company at a price of US$330 per share. The January 1, 2014 payment was not paid by the Company, and subsequent to the schedule payment date, the agreement was terminated. Glottech Technology On March 17, 2011 and subsequently amended on November 18, 2011, the Company entered into a letter agreement to acquire one initial unit of proprietary and patented mechanical ultrasound technology for use in water purification, inclusive of its process of separating from water, as the primary fluid stock, the salt and other minerals and by –products contained therein, with Glottech – USA. To acquire the unit, the Company must make the following payments: a) US$25,000 upon execution of the agreement (paid); b) US$75,000 within 180 days of execution of the agreement (paid); c) US$700,000 within 10 days of receipt of invoice from Glottech –USA LLC if the payment in b) is made (paid). d) The Company also granted an option to acquire 500 shares for $1.00 to Glottech – USA upon receipt of the operational ultrasonic generator that they are building for Lithium Exploration Group. The 500 shares are to be paid from outstanding shares owned by Alex Walsh, company CEO. During the year ended June 30, 2011, the option resulting in additional mining expenses of $4,940,000 was valued using the fair market value of the shares to be issued. On October 1, 2012, Alex Walsh and GD International entered into an agreement to transfer 500 common shares owned by Alex Walsh to GD International. The shares were received by GD International on October 29, 2012. Commencing as of the end of an initial sixty day testing and training period following satisfactory delivery and physical setup of the technology, and continuing thereafter for as long as the technology remains in the possession of the Company, the Company shall pay continuing monthly royalties in an amount equal to $2.00 per physical ton of water processed pursuant to the usage of the technology. On June 12, 2012, the Company filed a complaint with the court of common pleas of Chester County, Pennsylvania against Glottech – USA, LLC, Eldredge, Inc., and the Eldredge Companies, Inc. The complaint seeks an order of the court granting possession of the unit, in its current state, to the Company. Effective August 14, 2012, the Company entered into an option agreement with GD Glottech-International, Limited (“GD International”) to protect our license and distribution rights in the event that GD-Glottech-USA, LLC (“GD USA”) is unable to perform and honor the obligations contingent to a letter agreement dated November 8, 2011. Pursuant to the terms of the option agreement, we are required to provide an initial deposit of $150,000 to be held in escrow for the option to obtain a license on the patent rights, as set forth in the option agreement. A further $15,000 was required for exercising the option agreement and it will be credited to future fees when patents rights are exercised. We exerised this option agreement on September 1, 2012 and released the funds to GD International. On October 1, 2012, the Company entered into a sales agency agreement with GD International. The agreement shall replace all agreements entered previously. Pursuant to the agreement, the Company is appointed as GD International’s sales agent for the technology within the territory. As a consideration, 10,000 common shares of the Company shall be issued to GD International (issued: see d) above). GD International retains all right, title and interest in the technology. The term of this agreement will be an initial period of five years. The term shall be automatically renewable thereafter for successive five year periods provided that the Company has sold not less than 25 or more technology units during each applicable five year period. On May 2, 2013, the Company entered into an agreement to retain the future use of the unit. Pursuant to the agreement, the Company must make the following payments: a) US$20,000 within three days of execution of the agreement (paid); b) US$30,000 within three days upon the testing of the unit has been successfully completed.

Convertible Promissory Notes

Convertible Promissory Notes	3 Months Ended
	Sep. 30, 2015
Convertible Promissory Notes [Text Block]	6. Convertible Promissory Notes Summary of convertible promissory note at September 30, 2015 and June 30, 2015 is as follows: June 30, Principal Total Total September 30, 2015 Issued converted repaid 2015 February 13, 2013 $ 67,913 $ $ (13,140 ) $ - $ 54,773 March 15, 2014 29,394 - (22,755 ) - 6,639 July 22, 2014 540,498 - (46,408 ) - 494,090 August 22, 2014 37,243 - (5,200 ) - 32,043 February 6, 2015 75,000 - (20,000 ) - 55,000 February 24, 2015 100,000 - - 100,000 March 3, 2015 29,000 - (3,000 ) - 26,000 August 3, 2015 - 36,000 - - 36,000 September 9, 2015 - 30,000 - 30,000 September 30, 2015 - 27,000 - 27,000 $ 879,048 $ 93,000 $ (110,503 ) $ - $ 861,545 Less: Unamortized debt discount $ (345,054 ) $ (264,341 ) Total note payable, net of debt discount $ 533,994 $ 597,204 Current portion $ 533,994 $ 597,204 Long term portion $ - $ - On August 03, 2015 the Company issued an aggregate of $36,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear 10% interest per annum and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $52,720 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 269.35% Risk free rate: 0.17% The initial fair values of the embedded debt derivative of $33,231 was allocated as a debt discount up to the proceeds of the note with the remainder $19,489 was charged to current period operations as interest expense. On September 09, 2015, the Company issued an aggregate of $30,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear 10% interest per annum and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $54,495 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 275.84% Risk free rate: 0.39% The initial fair values of the embedded debt derivative $30,000 was allocated as a debt discount up to the proceeds of the note with the remainder $24,495 was charged to current period operations as interest expense. On September 30, 2015, Company issued an aggregate of $27,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear 10% interest per annum and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $306,808 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 375.79% Risk free rate: 0.33% The initial fair values of the embedded debt derivative $27,000 was allocated as a debt discount up to the proceeds of the note with the remainder $279,808 was charged to current period operations as interest expense. During the three months period ending September 30, 2015 the Company amortized the debt discount on all the notes $170,943 to operations as interest expense, respectively. Derivative Liability- Debt The fair value of the described embedded derivative on all debt was valued at $9,449,354 and $1,646,448 at September 30, 2015 and June 30, 2015, respectively, which was determined using the Black Scholes Model with the following assumptions: September 30, June 30, 2015 2015 Dividend yield: 0% 0% Volatility 375.79% 258.89% Risk free rate: . 08% - .64% . 11% - . 64% At September 30, 2015 and 2014, the Company adjusted the recorded fair value of the derivative liability on debt to market resulting in non-cash, non-operating loss of $7,589,738 and gain of $242,883 for the three months ended September 30, 2015 and 2014, respectively. During the three months ended September 30, 2015 the Company issued 3,533,472 no of shares of the Company common stock in settlement of $110,503 of convertible note and interest. During the three months ended September 30, 2015 the Company reclassed the derivative liability debt of $200,856 to additional paid in capital on conversion of convertible note. The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of September 30, 2015 and June 30, 2015: Derivative Liability (convertible promissory notes) Balance, June 30, 2014 $ 3,006,171 Initial fair value at note issuances 1,227,384 Fair value of liability at note conversion (3,174,990 ) Mark-to-market at June 30, 2014 527,883 Balance, June 30, 2015 $ 1,646,448 Initial fair value at note issuances 414,024 Fair value of liability at note conversion (200,856 ) Mark-to-market at September 30, 2015 7,589,738 Balance, September 30, 2015 $ 9,449,354 Net loss for the period included in earnings relating to the liabilities held at September 30, 2015 $ 7,589,738 Derivative Liability- Warrants Along with the promissory notes, the Company issued warrants that bear a cashless exercise provision. The warrants also include anti-dilution protection with respect to lower priced issuances of common stock or securities convertible or exchangeable into common stock, which provision resulted in derivative liability treatment under ASC 480. The warrants are recorded at fair value using the Black-Scholes option pricing model and marked-to-market at each reporting period, with the changes in the fair value recorded in the consolidated statement of operations and comprehensive income (loss). During the three months ended September 30, 2015 no warrants were issued along with convertible note. The fair value of the described embedded derivative on all warrants was valued at $995,411 at September 30, 2015 and $143,375 at June 30, 2015 which was determined using the Black Scholes Model with the following assumptions: September 30, June 30, 2015 2015 Dividend yield: 0% 0% Volatility 356.75% 288.96% Risk free rate: . 92% – 1.37% 1.01% - 1.63% Warrants Weighted Weighted Outstanding Average Average Exercise Remaining Price life Balance, June 30, 2014 15,204 $ 242.57 2.62 years Warrants issued 19,104 236.92 4.46 years Exercised (5,927 ) 257.08 - Cancelled - - - Expired (1,289 ) 240.00 - Balance, June 30, 2015 27,092 $ 100.98 3.79 years Warrants issued - - - Exercised - - - Cancelled - - - Expired - - - Balance, September 30, 2015 27,092 $ 100.98 3.54 years The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of September 30, 2015 and June 30, 2015: Derivative Liability (warrants) Balance, June 30, 2014 $ 5,416,000 Initial fair value of warrant derivatives at note issuances 791,407 Fair value of warrant exercised (2,730,022 ) Mark-to-market at June 30, 2014 – warrant liability (3,334,009 ) Balance, June 30, 2015 $ 143,376 Initial fair value of warrant derivatives at note issuances - Fair value of warrant exercised - Mark-to-market at September 30, 2015 – warrant liability 852,035 Balance, September 30, 2015 $ 995,411 Net loss for the period included in earnings relating to the liabilities held at September 30, 2015 $ 852,035 At September 30, 2015 and 2014, the Company adjusted the recorded fair value of the derivative liability on warrants to market resulting in non-cash, non-operating loss of $852,035 and gain of $2,980,546 for the three months ended September 30, 2015 and 2014, respectively. During the three months ended September 30, 2015 the Company reclassed the derivative liability on warrants of $0 to additional paid in capital on exercise of warrants.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Sep. 30, 2015
Related Party Transactions [Text Block]	7. Related Party Transactions During the three months ended September 30, 2015, the Company incurred consulting fees of $815 (June 30, 2015 - $157,086) with directors and officers out of which there were no stock payments (June 30, 2015 - $58,990 were paid by issuance of 2,167 shares of the Company common stock). As of September 30, 2015, the Company repaid to a director for a non-interest bearing demand loan of $nil (Note 9) (June 30, 2015 – payable $47,537). These transactions are in the normal course of operations and are measured at the exchange amount of consideration established and agreed to by the related parties.

Going Concern and Liquidity Con

Going Concern and Liquidity Considerations	3 Months Ended
	Sep. 30, 2015
Going Concern and Liquidity Considerations [Text Block]	8. Going Concern and Liquidity Considerations The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. As at September 30, 2015, the Company had a working capital deficiency of $11,267,263 (June 30, 2015 - $2,456,477) and an accumulated deficit of $58,713,588 (June 30, 2015 - $49,567,348). The Company intends to fund operations through equity financing arrangements, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the next twelve months. The ability of the Company to emerge from the exploration stage is dependent upon, among other things, obtaining additional financing to continue operations, explore and develop the mineral properties and the discovery, development and sale of ore reserves. In response to these problems, management intends to raise additional funds through public or private placement offerings. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Sep. 30, 2015
Commitments and Contingencies [Text Block]	9. Commitments and Contingencies Employment Agreements On January 12, 2014, the Company entered into an employment agreement with a director and officer. Commencing on January 12, 2014, the director and officer will be employed for 24 months ending on January 12, 2016. Pursuant to the agreement, annual salary of US$120,000 is payable monthly in cash or if the Company does not have available cash, in shares of the Company’s common stock. Consulting Agreements On January 1, 2014, the Company entered in a consulting agreement with a consultants to provide services as members of the Board of Directors in regards to the Company’s management and operations. The compensation for the services to be provided will be $12,000 payable monthly in cash or if the Company does not have available cash, in shares of the Company’s common stock. The consulting agreement was amended on October 22, 2014 to include an additional aggregate of $30,000 payable as of October 22, 2014 in cash or in shares of the Company’s common stock, and changed the term of agreement from 12 months to 10 months. Effective November 1, 2014, the consultant resigned as member of the Board of Directors. On April 28, 2014, the Company entered into a consulting agreement with a consultant to provide services as members of the Board of Directors in regards to the Company’s management and operations. Pursuant to the terms of the agreement, the consultant will receive compensation of $12,000 in unregistered restricted common shares of the Company's common stock at a deemed value of $200.0 per share, issuable on May 15, 2014, effective April 28, 2014 to April 27, 2015. The consultant resigned as member of the Board of Directors and these shares were not issued. On May 30, 2014, the Company entered into a consulting agreement with a consultant to provide services as member of the Board of Directors in regards to the Company’s management and operation. The compensation for the services to be provided will be $10,000 per month payable in common stock of the Company from a period of six months from the effective date of May 30, 2014. On August 1, 2014, the Company entered into a consulting agreement with a consultant to provide advice relative to corporate and business services and to perform other related activities. Pursuant to the terms of the agreement, the Company will issue 500 common shares of the Company valued at $5,000. These shares were issued in full effective October 22, 2014. Lease Commitment On May 15, 2014, the Company entered into a sublease agreement for a term of twenty four and one half months and expiring on May 31, 2016. Future minimum rental payments required under operating lease (exclusive of other additional rent payments) are $30,044. Litigation From time to time we may be a defendant and plaintiff in various other legal proceedings arising in the normal course of our business. Except as disclosed above, we are currently not a party to any material legal proceedings or government actions, including any bankruptcy, receivership, or similar proceedings. In addition, we are not aware of any known litigation or liabilities involving the operators of our properties that could affect our operations. Furthermore, as of the date of this Annual Report, our management is not aware of any proceedings to which any of our directors, officers, or affiliates, or any associate of any such director, officer, affiliate, or security holder is a party adverse to our company or has a material interest adverse to us.

Loan Receivable

Loan Receivable	3 Months Ended
	Sep. 30, 2015
Loan Receivable [Text Block]	10. Loan Receivable Secured Bridge Loan Agreement On December 18, 2013, the Company entered into an agreement with GD Glottech International Ltd (“GDGI”) whereby the Company loaned to GDGI the sum of $20,000. GDGI will repay the total amount of the loan plus interest in the amount of $333.34 (representing a 10% annual interest rate), within sixty (60) days from the receipt of the loan funds or within five (5) days of Sonic Cavitation, LLC receiving a 5% Capital Contribution. On April 21, 2014, the Company entered into an amended agreement with Sonic Cavitation, whereby Sonic Cavitation agreed to facilitate the construction of one sonic cavitation generator. The Company agreed to pay Sonic Cavitation a consulting fee of $20,000 upon execution of the agreement and forgive the sum of $20,000 debt upon delivery of the prototype by Sonic Cavitation. The agreement has been executed, however the delivery of the prototype has not yet fulfilled. During the three months ending September 30, 2015, the directors of the company decided that the loan is irrecoverable and has been written off to $nil.

Discontinued Operations

Discontinued Operations	3 Months Ended
	Sep. 30, 2015
Discontinued Operations [Text Block]	11. Discontinued Operations On September 4, 2015, the Company entered into an Asset Purchase agreement whereby the Company sells the net assets of Alta Disposal Morinville Ltd. (of which the Company had acquired 51% interest on October 18, 2013) for total purchase price of CDN$10,000. Operating results for the quarter ended September 30, 2015 and 2014 for Alta Disposal Morinville Ltd. are presented as discontinued operations and the assets and liabilities classified as held for sale are presented separately in the consolidated balance sheet. A breakdown of the discontinued operations is presented as follow: Consolidated Statements of Operations and Comprehensive Loss September 30, September 2015 30, 2014 Revenue $ - $ 16,067 Selling, general and administrative $ (54,074 ) (164,638 ) Loss from discontinued operations $ (54,074 ) $ (148,571 ) Consolidated Balance Sheets September 30, June 30, 2015 2015 Current assets: Cash and cash equivalents $ 23,820 $ 46,731 Receivable, net 22,679 28,160 Prepaid expenses - - Impairment of net assets - (60,178 ) $ 46,499 14,713 Current liabilities: Accounts payable $ 6,236 $ 6,696

Subsequent Events

Subsequent Events	3 Months Ended
	Sep. 30, 2015
Subsequent Events [Text Block]	12. Subsequent Events Issuances of Common Shares On October 8, 2015, the Company issued 8,044 common shares at a deemed price of $0.0001 per share to the depository trust as a result of the reverse stock split. On October 28, 2015 the Company issued 554,000 common shares at a deemed price of $0.01 per share for promissory note conversion. Convertible Promissory Notes On November 6, 2015, the Company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $12,000, with an issuance discount of 10% and maturity of one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of the company’s common stock. On December 1, 2015, the Company entered into a securities purchase agreement with an investor pursuant to which the investor acquired a convertible promissory note with an aggregate face value of $18,000, which amount includes the purchase price of $15,000, $1,500 for pre-paid interest at the rate of 10% for 12 months, and $1,500 in respect of legal fees incurred by the investor. The convertible note has a maturity date of December 1, 2016 and is convertible, at the option of the holder, in whole or in part, into shares of the company’s common stock at price per share equal to 65% of the lowest reported sale price of the Company’s common stock during the 20 trading days prior to December 1, 2015 or prior to the applicable conversion date. On December 1, 2015, the Company entered into a second securities purchase agreement with an investor pursuant to which the investor acquired a convertible promissory note with an aggregate face value of $18,000, which amount includes the purchase price of $15,000, $1,500 for pre-paid interest at the rate of 10% for 12 months, and $1,500 in respect of legal fees incurred by the investor. The convertible note has a maturity date of December 1, 2016 and is convertible, at the option of the holder, in whole or in part, into shares of the company’s common stock at price per share equal to 65% of the lowest reported sale price of the Company’s common stock during the 20 trading days prior to December 1, 2015 or prior to the applicable conversion date. On December 3, 2015, the Company issued 10% convertible redeemable note. Pursuant to the terms of the agreement, the investor acquired a convertible note with an aggregate face value of $17,000 with a maturity of one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of the company’s common stock at 65% of lowest trading price at the date of conversion. The Company has evaluated subsequent events from October 1, 2015, through the date of this report, and determined there are no other items to disclose. Subsequent to the issuance of June 30, 2015 financial statements, management determined that the warrants issued were incorrectly valued and derivative liability on the conversion option embedded in convertible notes was not recognized and during the three months period ending September 30, 2015, these warrants were revalued and a derivative liability on the conversion option was calculated. As a result of revaluation of the warrants, the consolidated balance sheet for the year ending June 30, 2015, the consolidated statements of operations and comprehensive income (loss) and consolidated statement of cash flows for the three months period ending September 30, 2014 and consolidated statements of changes in stockholders’ deficit for the period ending June 30, 2014 and June 30, 2015 were restated.

Restatement to previously issue

Restatement to previously issued financial statements	3 Months Ended
	Sep. 30, 2015
Restatement to previously issued financial statements [Text Block]	13. Restatement to previously issued financial statements The following tables reflect the corrections to the affected line items in the previously issued financial statements as of and for the years ended June 30, 2015 and for the quarter ended September 30, 2014. Effect on Condensed Consolidated Balance Sheet Year ended June 30, 2015 As previously Effect of Restatement As Restated reported ASSETS Current Cash and cash equivalents $ 64,099 $ - $ 64,099 Receivable 13,421 - 13,421 Loan receivable 20,000 - 20,000 Prepaid expenses 2,788 - 2,788 Current assets held for sale 14,713 - 14,713 Total current assets 115,021 - 115,021 Deposit on Alta Disposal Morinville Ltd. - - - Investment Held for Sale (Note 15) - - - Total Assets $ 115,021 $ - $ 115,021 LIABILITIES Current Accounts payable and accrued liabilities (note 9) $ 65,962 $ - $ 65,962 Derivative liability – warrants (Note 6) 3,134 140,241 143,375 Derivative liability – convertible promissory notes (Note 6) - 1,646,448 1,646,448 Due to related party (Note 8) 115,000 - 115,000 Convertible promissory notes (Note 6) 300,887 233,107 533,994 Accrued interest – convertible promissory notes (Note 6) 60,022 - 60,022 Liabilities of discontinued operations 6,696 - 6,696 Total Current Liabilities $ 551,701 $ 2,087,796 $ 2,571,497 STOCKHOLDERS’ DEFICIT Capital stock (Note 3) Authorized: Issued and outstanding: - - - 7,574,353 common shares (June 30, 2014 – 47,990) 7,575 - 7,575 Additional paid-in capital 43,165,743 4,217,489 47,383,232 Accumulated other comprehensive loss (29,484 ) - (29,484 ) Deficit accumulated during the exploration (43,267,064 ) (6,237,285 ) (49,504,349 ) Total Lithium Exploration Group, Inc. Stockholders’ Deficit (123,230 ) (2,019,796 ) (2,143,026 ) Non-controlling interest (313,450 ) - (313,450 ) Total Stockholders’ Deficit (436,680 ) (2,019,796 ) (2,456,476 ) Total Liabilities and Stockholders’ Deficit $ 115,021 $ - $ 15,021 Effect on Condensed Consolidated Statement of Operations and Comprehensive Income (Loss) Three months ended September 30, 2014 As previously Effect of reported Restatement As Restated Revenue $ 16,067 $ (16,067 ) $ - Operating Expenses: Mining (Notes 3 & 5) 15,000 - 15,000 Selling, general and administrative (Notes 3 & 5) 502,629 (164,638 ) 337,991 Total operating expenses 517,629 (164,638 ) 352,991 Loss from operations (501,562 ) 148,571 (352,991 ) Other income (expenses) Interest expense (Note 6) (1,562,421 ) 838,350 (724,071 ) Gain (loss) on change in the fair value of derivative liability (Note 6) 2,458,446 764,983 3,223,429 Fair Value of Warrants issued (397,070 ) 397,070 - Amortization of discount on debt discount - (709,644 ) (709,644 ) Equity in income of investment held for sale 48,423 - 48,423 (Loss) income before income taxes 45,816 1,439,329 1,485,145 Provision for Income Taxes (Note 4) - - - (Loss) income from continuing operations 45,816 1,439,329 1,485,145 (Loss) from discontinued operations - (148,571 ) (148,571 ) Net (loss) income 45,816 1,290,758 1,336,574 Less: Net (loss) income attributable to the non-controlling interest (72,800 ) - (72,800 ) Net (loss) income attributable to Lithium Exploration Group, Inc. Common shareholders $ 118,616 $ 1,290,758 $ 1,409,374 Basic and Diluted (loss) income per Common Share 0.00 33,87 22.24 Basic and Diluted Weighted Average Number of Common Shares Outstanding 253,441,532 (253,378,172 ) 63,360 Comprehensive (loss) income : Net (loss) income 45,816 1,290,758 1,336,574 Foreign currency translation adjustment (1,864 ) - (1,864 ) Comprehensive (loss) income 43,952 1,290,758 1,334,710 Comprehensive income (loss) attributable to non-controlling interest (72,800 ) - (72,800 ) Comprehensive (loss) income attributable to Lithium Exploration Group, Inc. $ 116,752 $ 1,290,758 $ 1,407,510 Effect on Condensed Consolidated Statements of Cash Flows Three months ending September 30, 2014 As previously Misstatement As Restated reported Adjustment Cash Flows from Operating Activities Net loss from continuing operations $ 45,816 $ 1,439,329 $ 1,485,145 Loss from discontinued operations - (148,571 ) (148,571 ) Adjustments to reconcile net loss to net cash used in operating activities: Equity in income of investment held for sale (48,423 ) - (48,423 ) Common shares issued for consulting fees 87,000 - 87,000 Interest expense 1,478,356 (838,350 ) 640,006 Amortization of discount on derivative liabilities - 709,644 709,644 Bad debt written-off - - - Common shares issued for interest expenses 31,642 - 31,642 (Gain) loss on change in the fair value of derivative liability (2,458,446 ) (764,983 ) (3,223,429 ) Fair value of warrants issued 397,070 (397,070 ) - Changes in operating assets and liabilities: Receivable, net 4,147 (4,147 ) - Prepaid expenses 18,976 (2,366 ) 16,610 Accrued interest 52,423 - 52,423 Accounts payable and accrued liabilities 101,391 (62,110 ) 39,281 Net cash used in operating activities from continuing operations (290,048 ) (68,623 ) (358,671 ) Net cash used in operating activities from discontinued operations - 65,941 65,941 Net cash used in operating activities (290,048 ) (2,682 ) (292,730 ) Cash Flows from Financing Activities Proceed from issuance of convertible promissory notes 400,000 - 400,000 Net cash provided by financing activities 400,000 - 400,000 Effect of foreign exchange (1,864 ) - (1,864 ) Increase (decrease) in cash and cash equivalents 108,088 (2,684 ) 105,406 Cash and cash equivalents - beginning of period 69,732 (12,100 ) 57,632 Cash and cash equivalents - end of period $ 177,820 $ (14,782 ) $ 163,038 Supplementary disclosure of cash flow information: Cash paid during the period for: $ - $ - Interest $ - $ - Income taxes Supplementary non- cash Investing and Financing Activities: Non-cash investing and financing activities Common stock issued for debt conversion $ 986,034 $ (462,368 ) $ 523,666 Transfer of beneficial conversion feature to fair value of note $ 215,385 $ (215,385 ) $ - Common stock issued on cashless exercise of warrants $ 766,675 $ 1,605,259 $ 2,371,934 Derivative liability re-classed to additional paid in capital $ - $ 919,506 $ 919,506 Debt discount on convertible note and warrants $ - $ 367,333 $ 367,333 Initial derivative liability on note issuance $ - $ 1,007,232 $ 1,007,232 Effect on Condensed Consolidated Statements of Changes in Stockholders’ Deficit Year ended June 30, 2015 As previously reported As Restated Misstatement Adjustment Additional Paid in Capital Beginning Balance $ 38,573,856 $ 538,043 $ 39,111,899 Common shares issued for debt conversion 3,636,984 (1,457,586 ) 2,179,398 Common shares issued for exercise of warrants 767,879 1,962,041 2,729,920 Common shares issued for reclassification of derivative liability on convertible notes - 3,174,990 3,174,990 Closing Balance $ 43,165,743 $ 4,217,488 $ 47,383,231 Accumulated deficit Beginning Balance $ (40,821,871 ) $ (6,166,108 ) $ (46,987,979 ) Net loss for the period (2,445,193 ) (71,176 ) (2,516,369 ) Closing Balance $ (43,267,064 ) $ (6,237,283 ) $ (49,504,347 ) Total Equity Beginning Balance $ (2,355,136 ) $ (5,628,065 ) $ (7,983,201 ) Common shares issued for consulting fees 118,990 118,990 Common shares issued for investor relations 68,000 68,000 Common shares issued for exercise of warrants 767,981 1,962,039 2,730,020 Common shares issued for debt conversion 3,644,405 (1,457,585 ) 2,186,820 Common shares issued for reclassification of derivative liability on convertible notes - 3,174,990 3,174,990 Common shares issued to trust 38 - 38 Foreign exchange translation (23,715 ) (23,715 ) Net loss for the period (2,657,243 ) (71,176 ) (2,728,419 ) Closing Balance $ (436,680 ) $ (2,019,797 ) $ (2,456,477 )

Summary of Significant Accounti

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Sep. 30, 2015
Basis of presentation and consolidation [Policy Text Block]	Basis of presentation and consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. These interim financial statements as of and for the three months ended September 30, 2015 and 2014 are unaudited; however, in the opinion of management, such statements include all adjustments (consisting of normal recurring accruals) necessary to present fairly the financial position, results of operations and cash flows of the Company for the periods presented. The results for the three months ended September 30, 2015 are not necessarily indicative of the results to be expected for the year ending June 30, 2016 or for any future period. All references to September 30, 2015 and 2014 in these footnotes are unaudited. These unaudited condensed consolidated financial statements should be read in conjunction with our audited financial statements and the notes thereto for the year ended June 30, 2015, included in the Company’s annual report on Form 10-K filed with the SEC on December 3, 2015. The condensed balance sheet as of June 30, 2015 has been restated during the period ending September 30, 2015, and do not include all disclosures required by the accounting principles generally accepted in the United States of America.
Principal of Consolidation [Policy Text Block]	Principal of Consolidation The consolidated financial statements include the accounts of the Company, its wholly-owned subsidiary Alta Disposal Ltd. and its 51% owned subsidiary Alta Disposal Morinville Ltd. (formerly Bluetap Resources Ltd.). Intercompany accounts and transactions have been eliminated in consolidation in conformity with the applicable accounting framework.
Use of Estimates [Policy Text Block]	Use of Estimates The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s periodic filings with the Securities and Exchange Commission include, where applicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and future operations of the Company. Significant estimates that may materially change in the near term include the valuation of derivative liabilities and the underlying warrants, as well as fair value of investments.
Cash and Cash Equivalents [Policy Text Block]	Cash and Cash Equivalents Cash and cash equivalents include cash in banks, money market funds, and certificates of term deposits with original maturities of less than three months, which are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss in value. The Company had $34,577 and $64,099 in cash and cash equivalents at September 30, 2015 and June 30, 2015, respectively.
Concentration of Risk [Policy Text Block]	Concentration of Risk The Company maintains cash balances at a financial institution which, from time to time, may exceed Federal Deposit Insurance Corporation insured limits for banks located in the US. As of September 30, 2015 and June 30, 2015, the Company had $Nil and $Nil, respectively, in deposits in excess of federally insured limits in its US bank. The Company has not experienced any losses with regard to its bank accounts and believes it is not exposed to any risk of loss on its cash in bank accounts.
Prepaid expenses [Policy Text Block]	Prepaid expenses Prepaid expenses consist of security deposit for office lease which will be expensed or refunded at the end of the lease period.
Start-Up Costs [Policy Text Block]	Start-Up Costs In accordance with FASC 720-15-20 “ Start-Up Costs,”
Mineral Acquisition and Exploration Costs [Policy Text Block]	Mineral Acquisition and Exploration Costs The Company has been in the exploration stage since its formation on May 31, 2006. It is primarily engaged in the acquisition, exploration, and development of mining properties. Mineral property acquisition and exploration costs are expensed as incurred. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs incurred to develop such property are capitalized. Such costs will be amortized using the units-of-production method over the estimated life of the probable reserves.
Concentrations of Credit Risk [Policy Text Block]	Concentrations of Credit Risk The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.
Net Income or (Loss) per Share of Common Stock [Policy Text Block]	Net Income or (Loss) per Share of Common Stock The Company has adopted FASC Topic No. 260, “ Earnings Per Share Potentially dilutive securities are not presented in the computation of EPS since their effects are anti-dilutive.
Foreign Currency Translations [Policy Text Block]	Foreign Currency Translations The Company’s functional and reporting currency is the US dollar. All transactions initiated in other currencies are translated into US dollars using the exchange rate prevailing on the date of transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the US dollar at the rate of exchange in effect at the balance sheet date. Unrealized exchange gains and losses arising from such transactions are deferred until realization and are included as a separate component of stockholders’ equity (deficit) as a component of comprehensive income or loss. Upon realization, the amount deferred is recognized in income in the period when it is realized. Translation of Foreign Operations The financial results and position of foreign operations whose functional currency is different from the Company’s presentation currency are translated as follows: Exchange differences arising on translation of foreign operations are transferred directly to the Company’s accumulated other comprehensive loss in the consolidated balance sheets. Transaction gains and losses arising from exchange rate fluctuation on transactions denominated in a currency other than the functional currency are included in the consolidated statements of operations. The relevant translation rates are as follows: For the period ending September 30, 2015 closing rate at 0.7466 CDN$: US$, average rate at 0.7637 CDN$: US$ and for the year ended June 30, 2015 closing rate at 0.8017 CDN$: US$, average rate at 0.8518 CDN$: US$.
Comprehensive Income (Loss) [Policy Text Block]	Comprehensive Income (Loss) FASC Topic No. 220, “ Comprehensive Income,”
Risks and Uncertainties [Policy Text Block]	Risks and Uncertainties The Company operates in the resource exploration industry that is subject to significant risks and uncertainties, including financial, operational, technological, and other risks associated with operating a resource exploration business, including the potential risk of business failure.
Environmental Expenditures [Policy Text Block]	Environmental Expenditures The operations of the Company have been, and may in the future be, affected from time to time in varying degree by changes in environmental regulations, including those for future reclamation and site restoration costs. Both the likelihood of new regulations and their overall effect upon the Company vary greatly and are not predictable. The Company's policy is to meet or, if possible, surpass standards set by relevant legislation by application of technically proven and economically feasible measures. Environmental expenditures that relate to ongoing environmental and reclamation programs are charged against earnings as incurred or capitalized and amortized depending on their future economic benefits. All of these types of expenditures incurred since inception have been charged against earnings due to the uncertainty of their future recoverability. Estimated future reclamation and site restoration costs, when the ultimate liability is reasonably determinable, are charged against earnings over the estimated remaining life of the related business operation, net of expected recoveries.
Warrants [Policy Text Block]	Warrants The Company accounts for currently outstanding detachable warrants to purchase common stock as derivative liabilities as they are freestanding derivative financial instruments. The warrants are recorded as derivative liabilities at fair value, estimated using a Black-Scholes option pricing model, and marked to market at each balance sheet date, with changes in the fair value of the derivative liabilities recorded in the condensed consolidated statements of operations and comprehensive Income (Loss).
Convertible Instruments [Policy Text Block]	Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815 “Derivatives and Hedging”. It provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of notes redemption.
Fair Value of Financial Instruments [Policy Text Block]	Fair Value of Financial Instruments ASC 820, “Fair Value Measurements and Disclosures” Level 1 - Quoted prices in active markets for identical assets or liabilities; Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing. The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, prepaid expenses, deposit, accounts payable and accrued liabilities, and due to a related party approximate their fair values because of the short maturity of these instruments. The Company’s Level 3 financial liabilities consist of the liability of the Company’s secured convertible promissory notes and debentures issued to investors, and the derivative warrants issued in connection with these convertible promissory notes and debentures. There is no current market for these securities such that the determination of fair value requires significant judgment or estimation. The Company used a fair value model which incorporates transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.
Revenue Recognition [Policy Text Block]	Revenue Recognition The Company has generated little revenues to date. It is the Company’s policy that revenue from product sales or services will be recognized in accordance with ASC 605 “Revenue Recognition”. Four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company will defer any revenue for which the product/services was not delivered or is subject to refund until such time that the Company and the customer jointly determine that the product/service has been delivered or no refund will be required. Sales comprise the fair value of the consideration received or receivable for the sale of goods and rendering of services in the ordinary course of the Company’s activities. Sales are presented, net of tax, rebates and discounts, and after eliminating intercompany sales. The Company recognizes revenue when the amount of revenue and related cost can be reliably measured and it is probable that the collectability of the related receivables is reasonably assured.
Income Taxes [Policy Text Block]	Income Taxes The Company recognizes the tax effects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reported for tax purposes. Deferred taxes are provided in the financial statements under FASC 740-20-20 to give effect to the resulting temporary differences which may arise from differences in the bases of fixed assets, depreciation methods, allowances, and start-up costs based on the income taxes expected to be payable in future years.
Receivables [Policy Text Block]	Receivables Trade and other receivables are customer obligations due under normal trade terms and are recorded at face value less any provisions for uncollectible amounts considered necessary. The Company includes any balances that are determined to be uncollectible in its overall allowance for doubtful accounts. The Company recorded $Nil (June 30, 2015 - $18,984) in allowance for doubtful accounts.
Recent Accounting Pronouncements [Policy Text Block]	Recent Accounting Pronouncements In August 2015, the FASB issued ASU 2015-15 “Interest – Imputation of Interest (Subtopic 835-30) – Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements (Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting).” The guidance issued previously in ASU 2015-03 did not address presentation or subsequent measurement of debt issuance costs related to line-of-credit arrangements. Given the absence of authoritative guidance within ASU 2015-03, the SEC staff stated that they would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments. In September 2015, the FASB issued ASU 2015-16 an update to its guidance on business combinations. The new guidance requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the measurement amounts are determined. The new guidance also requires that the acquirer records, in the same period’s financial statements, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed as of the acquisition date. The new guidance also requires an entity to present separately on the face of the income statement, or disclose in the notes, the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments.
FASB Statements [Policy Text Block]	FASB Statements: In June 2009 the FASB established the Accounting Standards Codification ("Codification" or "ASC") as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States ("GAAP"). Rules and interpretive releases of the Securities and Exchange Commission ("SEC") issued under authority of federal securities laws are also sources of GAAP for SEC registrants. Existing GAAP was not intended to be changed as a result of the Codification, and accordingly the change did not impact our financial statements. The ASC does change the way the guidance is organized and presented. Accounting Standards Updates ("ASUs") through ASU No. 2014-08 which contain technical corrections to existing guidance or affect guidance to specialized industries or entities were recently issued. These updates have no current applicability to the Company or their effect on the financial statements would not have been significant.

Provision For Income Taxes (Tab

Provision For Income Taxes (Tables)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	For the three months ended September 30, 2015 Amount Tax Effect ( 35%) Net loss $ 9,118,667 $ 3,191,533 Shares issued for consulting fees, mining expenses, investor relation and director fees Interest Expense (346,779 ) (121,373 ) Loss on derivative liability (8,441,773 ) (2,954,621 ) Amortization of discount (170,943 ) (59,830 ) Impairment (7,637 ) (2,673 ) Total 151,535 53,037 Valuation allowance (151,535 ) (53,037 ) Net deferred tax asset (liability) $ - $ -	For the three months ended September 30, 2014 Amount Tax Effect ( 35%) Net loss $ (1,336,574 ) $ (467,801 ) Shares issued for consulting fees, mining expenses, investor relation and director fees 87,000 30,450 Shares issued for interest expenses 31,642 11,075 Amortization of discount 709,644 248,376 Interest Expense 724,071 253,425 Gain on derivative liability (3,223,429 ) (1,128,200 ) Total 3,439,212 (1,052,676 ) Valuation allowance $ (3,439,212 ) $ 1,052,676 Net deferred tax asset (liability) $ - $ -

Convertible Promissory Notes (T

Convertible Promissory Notes (Tables)	3 Months Ended
	Sep. 30, 2015
Schedule of Summary of Convertible Promissory Note [Table Text Block]	June 30, Principal Total Total September 30, 2015 Issued converted repaid 2015 February 13, 2013 $ 67,913 $ $ (13,140 ) $ - $ 54,773 March 15, 2014 29,394 - (22,755 ) - 6,639 July 22, 2014 540,498 - (46,408 ) - 494,090 August 22, 2014 37,243 - (5,200 ) - 32,043 February 6, 2015 75,000 - (20,000 ) - 55,000 February 24, 2015 100,000 - - 100,000 March 3, 2015 29,000 - (3,000 ) - 26,000 August 3, 2015 - 36,000 - - 36,000 September 9, 2015 - 30,000 - 30,000 September 30, 2015 - 27,000 - 27,000 $ 879,048 $ 93,000 $ (110,503 ) $ - $ 861,545 Less: Unamortized debt discount $ (345,054 ) $ (264,341 ) Total note payable, net of debt discount $ 533,994 $ 597,204 Current portion $ 533,994 $ 597,204 Long term portion $ - $ -
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On August 03, 2015 [Table Text Block]	Dividend yield: 0% Volatility 269.35% Risk free rate: 0.17%
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On September 09, 2015 [Table Text Block]	Dividend yield: 0% Volatility 275.84% Risk free rate: 0.39%
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On September 30, 2015 [Table Text Block]	Dividend yield: 0% Volatility 375.79% Risk free rate: 0.33%
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	September 30, June 30, 2015 2015 Dividend yield: 0% 0% Volatility 375.79% 258.89% Risk free rate: . 08% - .64% . 11% - . 64%
Schedule of Changes in Fair Value of Convertible Promissory Notes [Table Text Block]	Derivative Liability (convertible promissory notes) Balance, June 30, 2014 $ 3,006,171 Initial fair value at note issuances 1,227,384 Fair value of liability at note conversion (3,174,990 ) Mark-to-market at June 30, 2014 527,883 Balance, June 30, 2015 $ 1,646,448 Initial fair value at note issuances 414,024 Fair value of liability at note conversion (200,856 ) Mark-to-market at September 30, 2015 7,589,738 Balance, September 30, 2015 $ 9,449,354 Net loss for the period included in earnings relating to the liabilities held at September 30, 2015 $ 7,589,738
Schedule of Stockholders' Equity Note, Warrants or Rights, Valuation Assumptions [Table Text Block]	September 30, June 30, 2015 2015 Dividend yield: 0% 0% Volatility 356.75% 288.96% Risk free rate: . 92% – 1.37% 1.01% - 1.63%
Schedule of Stockholders' Equity Warrants Activity [Table Text Block]	Warrants Weighted Weighted Outstanding Average Average Exercise Remaining Price life Balance, June 30, 2014 15,204 $ 242.57 2.62 years Warrants issued 19,104 236.92 4.46 years Exercised (5,927 ) 257.08 - Cancelled - - - Expired (1,289 ) 240.00 - Balance, June 30, 2015 27,092 $ 100.98 3.79 years Warrants issued - - - Exercised - - - Cancelled - - - Expired - - - Balance, September 30, 2015 27,092 $ 100.98 3.54 years
Schedule of Changes in Fair Value of Financial Liabilities [Table Text Block]	Derivative Liability (warrants) Balance, June 30, 2014 $ 5,416,000 Initial fair value of warrant derivatives at note issuances 791,407 Fair value of warrant exercised (2,730,022 ) Mark-to-market at June 30, 2014 – warrant liability (3,334,009 ) Balance, June 30, 2015 $ 143,376 Initial fair value of warrant derivatives at note issuances - Fair value of warrant exercised - Mark-to-market at September 30, 2015 – warrant liability 852,035 Balance, September 30, 2015 $ 995,411 Net loss for the period included in earnings relating to the liabilities held at September 30, 2015 $ 852,035

Discontinued Operations (Tables

Discontinued Operations (Tables)	3 Months Ended
	Sep. 30, 2015
Schedule of Discontinued Operations, Consolidated Statements of Operations and Comprehensive Loss [Table Text Block]	September 30, September 2015 30, 2014 Revenue $ - $ 16,067 Selling, general and administrative $ (54,074 ) (164,638 ) Loss from discontinued operations $ (54,074 ) $ (148,571 )
Schedule of Discontinued Operations, Consolidated Balance Sheets [Table Text Block]	Consolidated Balance Sheets September 30, June 30, 2015 2015 Current assets: Cash and cash equivalents $ 23,820 $ 46,731 Receivable, net 22,679 28,160 Prepaid expenses - - Impairment of net assets - (60,178 ) $ 46,499 14,713 Current liabilities: Accounts payable $ 6,236 $ 6,696

Restatement to previously iss24

Restatement to previously issued financial statements (Tables)	3 Months Ended
	Sep. 30, 2015
Schedule of Effect on Condensed Consolidated Balance Sheet [Table Text Block]	Year ended June 30, 2015 As previously Effect of Restatement As Restated reported ASSETS Current Cash and cash equivalents $ 64,099 $ - $ 64,099 Receivable 13,421 - 13,421 Loan receivable 20,000 - 20,000 Prepaid expenses 2,788 - 2,788 Current assets held for sale 14,713 - 14,713 Total current assets 115,021 - 115,021 Deposit on Alta Disposal Morinville Ltd. - - - Investment Held for Sale (Note 15) - - - Total Assets $ 115,021 $ - $ 115,021 LIABILITIES Current Accounts payable and accrued liabilities (note 9) $ 65,962 $ - $ 65,962 Derivative liability – warrants (Note 6) 3,134 140,241 143,375 Derivative liability – convertible promissory notes (Note 6) - 1,646,448 1,646,448 Due to related party (Note 8) 115,000 - 115,000 Convertible promissory notes (Note 6) 300,887 233,107 533,994 Accrued interest – convertible promissory notes (Note 6) 60,022 - 60,022 Liabilities of discontinued operations 6,696 - 6,696 Total Current Liabilities $ 551,701 $ 2,087,796 $ 2,571,497 STOCKHOLDERS’ DEFICIT Capital stock (Note 3) Authorized: Issued and outstanding: - - - 7,574,353 common shares (June 30, 2014 – 47,990) 7,575 - 7,575 Additional paid-in capital 43,165,743 4,217,489 47,383,232 Accumulated other comprehensive loss (29,484 ) - (29,484 ) Deficit accumulated during the exploration (43,267,064 ) (6,237,285 ) (49,504,349 ) Total Lithium Exploration Group, Inc. Stockholders’ Deficit (123,230 ) (2,019,796 ) (2,143,026 ) Non-controlling interest (313,450 ) - (313,450 ) Total Stockholders’ Deficit (436,680 ) (2,019,796 ) (2,456,476 ) Total Liabilities and Stockholders’ Deficit $ 115,021 $ - $ 15,021
Schedule of Effect on Condensed Consolidated Statement of Operations and Comprehensive Income (Loss) [Table Text Block]	Three months ended September 30, 2014 As previously Effect of reported Restatement As Restated Revenue $ 16,067 $ (16,067 ) $ - Operating Expenses: Mining (Notes 3 & 5) 15,000 - 15,000 Selling, general and administrative (Notes 3 & 5) 502,629 (164,638 ) 337,991 Total operating expenses 517,629 (164,638 ) 352,991 Loss from operations (501,562 ) 148,571 (352,991 ) Other income (expenses) Interest expense (Note 6) (1,562,421 ) 838,350 (724,071 ) Gain (loss) on change in the fair value of derivative liability (Note 6) 2,458,446 764,983 3,223,429 Fair Value of Warrants issued (397,070 ) 397,070 - Amortization of discount on debt discount - (709,644 ) (709,644 ) Equity in income of investment held for sale 48,423 - 48,423 (Loss) income before income taxes 45,816 1,439,329 1,485,145 Provision for Income Taxes (Note 4) - - - (Loss) income from continuing operations 45,816 1,439,329 1,485,145 (Loss) from discontinued operations - (148,571 ) (148,571 ) Net (loss) income 45,816 1,290,758 1,336,574 Less: Net (loss) income attributable to the non-controlling interest (72,800 ) - (72,800 ) Net (loss) income attributable to Lithium Exploration Group, Inc. Common shareholders $ 118,616 $ 1,290,758 $ 1,409,374 Basic and Diluted (loss) income per Common Share 0.00 33,87 22.24 Basic and Diluted Weighted Average Number of Common Shares Outstanding 253,441,532 (253,378,172 ) 63,360 Comprehensive (loss) income : Net (loss) income 45,816 1,290,758 1,336,574 Foreign currency translation adjustment (1,864 ) - (1,864 ) Comprehensive (loss) income 43,952 1,290,758 1,334,710 Comprehensive income (loss) attributable to non-controlling interest (72,800 ) - (72,800 ) Comprehensive (loss) income attributable to Lithium Exploration Group, Inc. $ 116,752 $ 1,290,758 $ 1,407,510
Schedule of Effect on Condensed Consolidated Statements of Cash Flows [Table Text Block]	Three months ending September 30, 2014 As previously Misstatement As Restated reported Adjustment Cash Flows from Operating Activities Net loss from continuing operations $ 45,816 $ 1,439,329 $ 1,485,145 Loss from discontinued operations - (148,571 ) (148,571 ) Adjustments to reconcile net loss to net cash used in operating activities: Equity in income of investment held for sale (48,423 ) - (48,423 ) Common shares issued for consulting fees 87,000 - 87,000 Interest expense 1,478,356 (838,350 ) 640,006 Amortization of discount on derivative liabilities - 709,644 709,644 Bad debt written-off - - - Common shares issued for interest expenses 31,642 - 31,642 (Gain) loss on change in the fair value of derivative liability (2,458,446 ) (764,983 ) (3,223,429 ) Fair value of warrants issued 397,070 (397,070 ) - Changes in operating assets and liabilities: Receivable, net 4,147 (4,147 ) - Prepaid expenses 18,976 (2,366 ) 16,610 Accrued interest 52,423 - 52,423 Accounts payable and accrued liabilities 101,391 (62,110 ) 39,281 Net cash used in operating activities from continuing operations (290,048 ) (68,623 ) (358,671 ) Net cash used in operating activities from discontinued operations - 65,941 65,941 Net cash used in operating activities (290,048 ) (2,682 ) (292,730 ) Cash Flows from Financing Activities Proceed from issuance of convertible promissory notes 400,000 - 400,000 Net cash provided by financing activities 400,000 - 400,000 Effect of foreign exchange (1,864 ) - (1,864 ) Increase (decrease) in cash and cash equivalents 108,088 (2,684 ) 105,406 Cash and cash equivalents - beginning of period 69,732 (12,100 ) 57,632 Cash and cash equivalents - end of period $ 177,820 $ (14,782 ) $ 163,038 Supplementary disclosure of cash flow information: Cash paid during the period for: $ - $ - Interest $ - $ - Income taxes Supplementary non- cash Investing and Financing Activities: Non-cash investing and financing activities Common stock issued for debt conversion $ 986,034 $ (462,368 ) $ 523,666 Transfer of beneficial conversion feature to fair value of note $ 215,385 $ (215,385 ) $ - Common stock issued on cashless exercise of warrants $ 766,675 $ 1,605,259 $ 2,371,934 Derivative liability re-classed to additional paid in capital $ - $ 919,506 $ 919,506 Debt discount on convertible note and warrants $ - $ 367,333 $ 367,333 Initial derivative liability on note issuance $ - $ 1,007,232 $ 1,007,232
Schedule of Effect on Condensed Consolidated Statements of Changes in Stockholders Deficit [Table Text Block]	Year ended June 30, 2015 As previously reported As Restated Misstatement Adjustment Additional Paid in Capital Beginning Balance $ 38,573,856 $ 538,043 $ 39,111,899 Common shares issued for debt conversion 3,636,984 (1,457,586 ) 2,179,398 Common shares issued for exercise of warrants 767,879 1,962,041 2,729,920 Common shares issued for reclassification of derivative liability on convertible notes - 3,174,990 3,174,990 Closing Balance $ 43,165,743 $ 4,217,488 $ 47,383,231 Accumulated deficit Beginning Balance $ (40,821,871 ) $ (6,166,108 ) $ (46,987,979 ) Net loss for the period (2,445,193 ) (71,176 ) (2,516,369 ) Closing Balance $ (43,267,064 ) $ (6,237,283 ) $ (49,504,347 ) Total Equity Beginning Balance $ (2,355,136 ) $ (5,628,065 ) $ (7,983,201 ) Common shares issued for consulting fees 118,990 118,990 Common shares issued for investor relations 68,000 68,000 Common shares issued for exercise of warrants 767,981 1,962,039 2,730,020 Common shares issued for debt conversion 3,644,405 (1,457,585 ) 2,186,820 Common shares issued for reclassification of derivative liability on convertible notes - 3,174,990 3,174,990 Common shares issued to trust 38 - 38 Foreign exchange translation (23,715 ) (23,715 ) Net loss for the period (2,657,243 ) (71,176 ) (2,728,419 ) Closing Balance $ (436,680 ) $ (2,019,797 ) $ (2,456,477 )

Organization (Narrative) (Detai

Organization (Narrative) (Details)	3 Months Ended
	Sep. 30, 2015USD ($)	Sep. 30, 2015CAD
Organization 1	1,617,437	1,617,437
Organization 2	51.00%	51.00%
Organization 3 | CAD		CAD 10,000
Organization 4 | $	$ 7,466
Organization 5	100.00%	100.00%
Organization 6	50.00%	50.00%
Organization 7	50.00%	50.00%
Organization 8	20	20
Organization 9	50.00%	50.00%
Organization 10	100.00%	100.00%

Significant Accounting Polici26

Significant Accounting Policies (Narrative) (Details)	3 Months Ended
	Sep. 30, 2015USD ($)
Significant Accounting Policies 1	51.00%
Significant Accounting Policies 2	$ 34,577
Significant Accounting Policies 3	64,099
Significant Accounting Policies 4	0
Significant Accounting Policies 5	$ 0
Significant Accounting Policies 6	0.7466
Significant Accounting Policies 7	0.7637
Significant Accounting Policies 8	0.8017
Significant Accounting Policies 9	0.8518
Significant Accounting Policies 10	$ 0
Significant Accounting Policies 11	$ 18,984

Capital Stock (Narrative) (Deta

Capital Stock (Narrative) (Details)	3 Months Ended
	Sep. 30, 2015USD ($)yr$ / sharesshares
Capital Stock 1	20
Capital Stock 2	1
Capital Stock 3	200
Capital Stock 4	1
Capital Stock 5	2,221,565,094
Capital Stock 6	11,107,825
Capital Stock 7	100,000,000
Capital Stock 8	100,000,000
Capital Stock 9 | $ / shares	$ 0.001
Capital Stock 10	600,000,000
Capital Stock 11	500,000,000
Capital Stock 12 | $ / shares	$ 0.001
Capital Stock 13	100,000,000
Capital Stock 14 | $ / shares	$ 0.001
Capital Stock 15	20,000,000
Capital Stock 16 | $ / shares	$ 0.001
Capital Stock 17 | $ / shares	$ 100
Capital Stock 18 | $	$ 0.001
Capital Stock 19	2,000,000
Capital Stock 20 | $ / shares	$ 0.001
Capital Stock 21 | $	$ 0.001
Capital Stock 22	1
Capital Stock 23 | $	$ 1
Capital Stock 24	500,000,000
Capital Stock 25 | $	$ 0.001
Capital Stock 26	2,000,000,000
Capital Stock 27 | $	$ 0.001
Capital Stock 28	2,000,000,000
Capital Stock 29	100,000,000
Capital Stock 30 | $	$ 0.001
Capital Stock 31	50,000,000
Capital Stock 32	100,000,000
Capital Stock 33 | $	$ 0.001
Capital Stock 34	62
Capital Stock 35 | yr	1
Capital Stock 36	75.00%
Capital Stock 37	2,000,000,000
Capital Stock 38 | $	$ 0.001
Capital Stock 39	10,000,000,000
Capital Stock 40 | $	$ 0.001
Capital Stock 41	125,000
Capital Stock 42 | $ / shares	$ 0.04
Capital Stock 43	201,465
Capital Stock 44 | $ / shares	$ 0.04
Capital Stock 45	250,000
Capital Stock 46 | $ / shares	$ 0.04
Capital Stock 47	100,000
Capital Stock 48 | $ / shares	$ 0.05
Capital Stock 49	298,269
Capital Stock 50 | $ / shares	$ 0.04
Capital Stock 51	250,000
Capital Stock 52 | $ / shares	$ 0.04
Capital Stock 53	80,801
Capital Stock 54 | $ / shares	$ 0.04
Capital Stock 55	434,084
Capital Stock 56 | $ / shares	$ 0.03
Capital Stock 57	438,000
Capital Stock 58 | $ / shares	$ 0.03
Capital Stock 59	486,623
Capital Stock 60 | $ / shares	$ 0.02
Capital Stock 61	475,000
Capital Stock 62 | $ / shares	$ 0.03
Capital Stock 63	394,231
Capital Stock 64 | $ / shares	$ 0.03
Capital Stock 65	50,000,000
Capital Stock 66	100,000,000
Capital Stock 67 | $	$ 0.001
Capital Stock 68	62
Capital Stock 69 | yr	1
Capital Stock 70	75.00%
Capital Stock 71	130,000
Capital Stock 72 | $	$ 0.001
Capital Stock 73	0

Provision For Income Taxes (Nar

Provision For Income Taxes (Narrative) (Details)	3 Months Ended
	Sep. 30, 2015USD ($)
Provision For Income Taxes 1	$ 12,974,856
Provision For Income Taxes 2	151,535
Provision For Income Taxes 3	$ 1,130,089

Mineral Property Costs (Narrati

Mineral Property Costs (Narrative) (Details) - 3 months ended Sep. 30, 2015	USD ($)d$ / sharesshares	CADdshares
Mineral Property Costs 1	100.00%	100.00%
Mineral Property Costs 2	$ 90,000
Mineral Property Costs 3	$ 90,000
Mineral Property Costs 4 | CAD		CAD 40,000
Mineral Property Costs 5 | CAD		60,000
Mineral Property Costs 6 | CAD		100,000
Mineral Property Costs 7 | CAD		300,000
Mineral Property Costs 8 | CAD		50,000
Mineral Property Costs 9 | CAD		100,000
Mineral Property Costs 10 | CAD		20,000
Mineral Property Costs 11 | CAD		CAD 80,000
Mineral Property Costs 12	15.00%	15.00%
Mineral Property Costs 13	15.00%	15.00%
Mineral Property Costs 14 | CAD		CAD 80,000
Mineral Property Costs 15	75.00%	75.00%
Mineral Property Costs 16 | CAD		CAD 100,000
Mineral Property Costs 17	$ 95,008
Mineral Property Costs 18 | CAD		20,000
Mineral Property Costs 19	19,164
Mineral Property Costs 20 | CAD		80,000
Mineral Property Costs 21	75,844
Mineral Property Costs 22 | CAD		106,667
Mineral Property Costs 23	101,125
Mineral Property Costs 24	26,667
Mineral Property Costs 25 | CAD		3,058
Mineral Property Costs 26	2,899
Mineral Property Costs 27 | CAD		80,000
Mineral Property Costs 28	75,844
Mineral Property Costs 29 | CAD		3,058
Mineral Property Costs 30	2,899
Mineral Property Costs 31 | CAD		CAD 83,058
Mineral Property Costs 32	$ 78,743
Mineral Property Costs 33 | shares	239	239
Mineral Property Costs 34 | $ / shares	$ 330
Mineral Property Costs 35	$ 25,000
Mineral Property Costs 36	$ 75,000
Mineral Property Costs 37 | d	180	180
Mineral Property Costs 38	$ 700,000
Mineral Property Costs 39 | d	10	10
Mineral Property Costs 40 | shares	500	500
Mineral Property Costs 41	$ 1
Mineral Property Costs 42 | shares	500	500
Mineral Property Costs 43	$ 4,940,000
Mineral Property Costs 44 | shares	500	500
Mineral Property Costs 45	$ 2
Mineral Property Costs 46	150,000
Mineral Property Costs 47	$ 15,000
Mineral Property Costs 48 | shares	10,000	10,000
Mineral Property Costs 49	25	25
Mineral Property Costs 50	$ 20,000
Mineral Property Costs 51	$ 30,000

Convertible Promissory Notes (N

Convertible Promissory Notes (Narrative) (Details)	3 Months Ended
	Sep. 30, 2015USD ($)
Convertible Promissory Notes 1	$ 36,000
Convertible Promissory Notes 2	10.00%
Convertible Promissory Notes 3	$ 52,720
Convertible Promissory Notes 4	33,231
Convertible Promissory Notes 5	19,489
Convertible Promissory Notes 6	$ 30,000
Convertible Promissory Notes 7	10.00%
Convertible Promissory Notes 8	$ 54,495
Convertible Promissory Notes 9	30,000
Convertible Promissory Notes 10	24,495
Convertible Promissory Notes 11	$ 27,000
Convertible Promissory Notes 12	10.00%
Convertible Promissory Notes 13	$ 306,808
Convertible Promissory Notes 14	27,000
Convertible Promissory Notes 15	279,808
Convertible Promissory Notes 16	170,943
Convertible Promissory Notes 17	9,449,354
Convertible Promissory Notes 18	1,646,448
Convertible Promissory Notes 19	7,589,738
Convertible Promissory Notes 20	$ 242,883
Convertible Promissory Notes 21	3,533,472
Convertible Promissory Notes 22	$ 110,503
Convertible Promissory Notes 23	200,856
Convertible Promissory Notes 24	995,411
Convertible Promissory Notes 25	143,375
Convertible Promissory Notes 26	852,035
Convertible Promissory Notes 27	2,980,546
Convertible Promissory Notes 28	$ 0

Related Party Transactions (Nar

Related Party Transactions (Narrative) (Details)	3 Months Ended
	Sep. 30, 2015USD ($)shares
Related Party Transactions 1	$ 815
Related Party Transactions 2	157,086
Related Party Transactions 3	$ 58,990
Related Party Transactions 4 | shares	2,167
Related Party Transactions 5	$ 0
Related Party Transactions 6	$ 47,537

Going Concern and Liquidity C32

Going Concern and Liquidity Considerations (Narrative) (Details)	3 Months Ended
	Sep. 30, 2015USD ($)
Going Concern And Liquidity Considerations 1	$ 11,267,263
Going Concern And Liquidity Considerations 2	2,456,477
Going Concern And Liquidity Considerations 3	58,713,588
Going Concern And Liquidity Considerations 4	$ 49,567,348

Commitments and Contingencies (

Commitments and Contingencies (Narrative) (Details)	3 Months Ended
	Sep. 30, 2015USD ($)mo$ / shares$ / moshares
Commitments And Contingencies 1 | mo	24
Commitments And Contingencies 2	$ 120,000
Commitments And Contingencies 3	12,000
Commitments And Contingencies 4	$ 30,000
Commitments And Contingencies 5 | mo	12
Commitments And Contingencies 6 | mo	10
Commitments And Contingencies 7	$ 12,000
Commitments And Contingencies 8 | $ / shares	$ 200
Commitments And Contingencies 9 | $ / mo	10,000
Commitments And Contingencies 10 | shares	500
Commitments And Contingencies 11	$ 5,000
Commitments And Contingencies 12	$ 30,044

Loan Receivable (Narrative) (De

Loan Receivable (Narrative) (Details)	3 Months Ended
	Sep. 30, 2015USD ($)
Loan Receivable 1	$ 20,000
Loan Receivable 2	$ 333.34
Loan Receivable 3	10.00%
Loan Receivable 4	5.00%
Loan Receivable 5	$ 20,000
Loan Receivable 6	20,000
Loan Receivable 7	$ 0

Discontinued Operations (Narrat

Discontinued Operations (Narrative) (Details)	3 Months Ended
	Sep. 30, 2015CAD
Discontinued Operations 1	51.00%
Discontinued Operations 2	CAD 10,000

Subsequent Events (Narrative) (

Subsequent Events (Narrative) (Details)	3 Months Ended
	Sep. 30, 2015USD ($)dmo$ / sharesshares
Subsequent Events 1 | shares	8,044
Subsequent Events 2 | $ / shares	$ 0.0001
Subsequent Events 3 | shares	554,000
Subsequent Events 4 | $ / shares	$ 0.01
Subsequent Events 5	10.00%
Subsequent Events 6	$ 12,000
Subsequent Events 7	10.00%
Subsequent Events 8	$ 18,000
Subsequent Events 9	15,000
Subsequent Events 10	$ 1,500
Subsequent Events 11	10.00%
Subsequent Events 12 | mo	12
Subsequent Events 13	$ 1,500
Subsequent Events 14	65.00%
Subsequent Events 15 | d	20
Subsequent Events 16	$ 18,000
Subsequent Events 17	15,000
Subsequent Events 18	$ 1,500
Subsequent Events 19	10.00%
Subsequent Events 20 | mo	12
Subsequent Events 21	$ 1,500
Subsequent Events 22	65.00%
Subsequent Events 23 | d	20
Subsequent Events 24	10.00%
Subsequent Events 25	$ 17,000
Subsequent Events 26	65.00%

Schedule of Deferred Tax Assets

Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 1	35.00%
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 2	$ 9,118,667
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 3	3,191,533
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 4	(346,779)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 5	(121,373)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 6	(8,441,773)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 7	(2,954,621)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 8	(170,943)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 9	(59,830)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 10	(7,637)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 11	(2,673)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 12	151,535
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 13	53,037
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 14	(151,535)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 15	(53,037)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 16	0
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 17	$ 0
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 1		35.00%
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 2		$ (1,336,574)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 3		(467,801)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 4		87,000
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 5		30,450
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 6		31,642
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 7		11,075
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 8		709,644
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 9		248,376
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 10		724,071
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 11		253,425
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 12		(3,223,429)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 13		(1,128,200)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 14		3,439,212
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 15		(1,052,676)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 16		(3,439,212)
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 17		1,052,676
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 18		0
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 19		$ 0

Schedule of Summary of Converti

Schedule of Summary of Convertible Promissory Note (Details)	3 Months Ended
	Sep. 30, 2015USD ($)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 1	$ 67,913
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 2	(13,140)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 3	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 4	54,773
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 5	29,394
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 6	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 7	(22,755)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 8	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 9	6,639
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 10	540,498
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 11	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 12	(46,408)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 13	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 14	494,090
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 15	37,243
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 16	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 17	(5,200)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 18	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 19	32,043
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 20	75,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 21	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 22	(20,000)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 23	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 24	55,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 25	100,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 26	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 27	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 28	100,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 29	29,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 30	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 31	(3,000)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 32	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 33	26,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 34	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 35	36,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 36	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 37	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 38	36,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 39	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 40	30,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 41	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 42	30,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 43	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 44	27,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 45	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 46	27,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 47	879,048
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 48	93,000
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 49	(110,503)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 50	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 51	861,545
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 52	(345,054)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 53	(264,341)
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 54	533,994
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 55	597,204
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 56	533,994
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 57	597,204
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 58	0
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 59	$ 0

Schedule of Share-based Payment

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On August 03, 2015 (Details)	3 Months Ended
	Sep. 30, 2015
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On August 03, 2015 1	0.00%
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On August 03, 2015 2	269.35%
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On August 03, 2015 3	0.17%

Schedule of Share-based Payme40

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On September 09, 2015 (Details)	3 Months Ended
	Sep. 30, 2015
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On September 09, 2015 1	0.00%
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On September 09, 2015 2	275.84%
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On September 09, 2015 3	0.39%

Schedule of Share-based Payme41

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On September 30, 2015 (Details)	3 Months Ended
	Sep. 30, 2015
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On September 30, 2015 1	0.00%
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On September 30, 2015 2	375.79%
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On September 30, 2015 3	0.33%

Schedule of Share-based Payme42

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)	3 Months Ended
	Sep. 30, 2015
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 1	0.00%
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 2	0.00%
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 3	375.79%
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 4	258.89%
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 5	8.00%
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 6	0.64%
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 7	11.00%
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 8	64.00%

Schedule of Changes in Fair Val

Schedule of Changes in Fair Value of Convertible Promissory Notes (Details)	3 Months Ended
	Sep. 30, 2015USD ($)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 1	$ 3,006,171
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 2	1,227,384
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 3	(3,174,990)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 4	527,883
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 5	1,646,448
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 6	414,024
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 7	(200,856)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 8	7,589,738
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 9	9,449,354
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 10	$ 7,589,738

Schedule of Stockholders' Equit

Schedule of Stockholders' Equity Note, Warrants or Rights, Valuation Assumptions (Details)	3 Months Ended
	Sep. 30, 2015
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 1	0.00%
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 2	0.00%
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 3	356.75%
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 4	288.96%
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 5	92.00%
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 6	1.37%
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 7	1.01%
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 8	1.63%

Schedule of Stockholders' Equ45

Schedule of Stockholders' Equity Warrants Activity (Details)	3 Months Ended
	Sep. 30, 2015USD ($)yr
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 1	$ 15,204
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 2	242.57
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 3 | yr	2.62
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 4	$ 19,104
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 5	236.92
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 6 | yr	4.46
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 7	$ (5,927)
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 8	257.08
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 9	$ 0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 10	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 11	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 12	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 13	$ (1,289)
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 14	240
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 15	$ 0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 16	$ 27,092
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 17	100.98
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 18 | yr	3.79
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 19	$ 0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 20	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 21	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 22	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 23	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 24	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 25	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 26	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 27	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 28	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 29	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 30	0
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 31	$ 27,092
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 32	100.98
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 33 | yr	3.54

Schedule of Changes in Fair V46

Schedule of Changes in Fair Value of Financial Liabilities (Details)	3 Months Ended
	Sep. 30, 2015USD ($)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 1	$ 5,416,000
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 2	791,407
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 3	(2,730,022)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 4	(3,334,009)
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 5	143,376
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 6	0
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 7	0
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 8	852,035
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 9	995,411
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 10	$ 852,035

Schedule of Discontinued Operat

Schedule of Discontinued Operations, Consolidated Statements of Operations and Comprehensive Loss (Details)	3 Months Ended
	Sep. 30, 2015USD ($)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 1	$ 30
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 2	0
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 3	16,067
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 4	(54,074)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 5	(164,638)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 6	(54,074)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 7	$ (148,571)

Schedule of Discontinued Oper48

Schedule of Discontinued Operations, Consolidated Balance Sheets (Details)	3 Months Ended
	Sep. 30, 2015USD ($)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 1	$ 23,820
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 2	46,731
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 3	22,679
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 4	28,160
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 5	0
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 6	0
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 7	0
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 8	(60,178)
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 9	46,499
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 10	14,713
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 11	6,236
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 12	$ 6,696

Schedule of Effect on Condensed

Schedule of Effect on Condensed Consolidated Balance Sheet (Details)	3 Months Ended
	Sep. 30, 2015USD ($)shares
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 1	$ 64,099
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 2	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 3	64,099
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 4	13,421
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 5	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 6	13,421
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 7	20,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 8	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 9	20,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 10	2,788
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 11	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 12	2,788
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 13	14,713
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 14	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 15	14,713
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 16	115,021
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 17	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 18	115,021
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 19	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 20	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 21	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 22	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 23	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 24	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 25	115,021
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 26	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 27	115,021
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 28	65,962
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 29	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 30	65,962
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 31	3,134
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 32	140,241
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 33	143,375
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 34	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 35	1,646,448
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 36	1,646,448
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 37	115,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 38	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 39	115,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 40	300,887
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 41	233,107
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 42	533,994
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 43	60,022
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 44	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 45	60,022
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 46	6,696
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 47	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 48	6,696
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 49	551,701
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 50	2,087,796
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 51	$ 2,571,497
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 52 | shares	100,000,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 53	$ 0.001
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 54 | shares	10,000,000,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 55	$ 0.001
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 56 | shares	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 57	$ 0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 58	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 59	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 60	$ 0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 61 | shares	7,574,353
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 62	$ 47,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 63	7,575
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 64	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 65	7,575
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 66	43,165,743
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 67	4,217,489
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 68	47,383,232
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 69	(29,484)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 70	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 71	(29,484)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 72	(43,267,064)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 73	(6,237,285)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 74	(49,504,349)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 75	(123,230)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 76	(2,019,796)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 77	(2,143,026)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 78	(313,450)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 79	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 80	(313,450)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 81	(436,680)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 82	(2,019,796)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 83	(2,456,476)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 84	115,021
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 85	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 86	$ 15,021

Schedule of Effect on Condens50

Schedule of Effect on Condensed Consolidated Statement of Operations and Comprehensive Income (Loss) (Details)	3 Months Ended
	Sep. 30, 2015USD ($)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 1	$ 16,067
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 2	(16,067)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 3	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 4	15,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 5	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 6	15,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 7	502,629
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 8	(164,638)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 9	337,991
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 10	517,629
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 11	(164,638)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 12	352,991
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 13	(501,562)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 14	148,571
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 15	(352,991)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 16	(1,562,421)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 17	838,350
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 18	(724,071)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 19	2,458,446
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 20	764,983
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 21	3,223,429
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 22	(397,070)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 23	397,070
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 24	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 25	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 26	(709,644)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 27	(709,644)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 28	48,423
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 29	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 30	48,423
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 31	45,816
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 32	1,439,329
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 33	1,485,145
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 34	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 35	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 36	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 37	45,816
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 38	1,439,329
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 39	1,485,145
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 40	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 41	(148,571)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 42	(148,571)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 43	45,816
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 44	1,290,758
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 45	1,336,574
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 46	(72,800)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 47	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 48	(72,800)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 49	118,616
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 50	1,290,758
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 51	$ 1,409,374
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 52	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 53	$ 3,387
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 54	22.24
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 55	$ 253,441,532
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 56	(253,378,172)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 57	63,360
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 58	45,816
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 59	1,290,758
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 60	1,336,574
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 61	(1,864)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 62	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 63	(1,864)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 64	43,952
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 65	1,290,758
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 66	1,334,710
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 67	(72,800)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 68	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 69	(72,800)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 70	116,752
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 71	1,290,758
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 72	$ 1,407,510

Schedule of Effect on Condens51

Schedule of Effect on Condensed Consolidated Statements of Cash Flows (Details)	3 Months Ended
	Sep. 30, 2015USD ($)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 1	$ 45,816
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 2	1,439,329
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 3	1,485,145
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 4	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 5	(148,571)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 6	(148,571)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 7	(48,423)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 8	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 9	(48,423)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 10	87,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 11	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 12	87,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 13	1,478,356
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 14	(838,350)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 15	640,006
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 16	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 17	709,644
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 18	709,644
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 19	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 20	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 21	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 22	31,642
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 23	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 24	31,642
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 25	(2,458,446)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 26	(764,983)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 27	(3,223,429)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 28	397,070
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 29	(397,070)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 30	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 31	4,147
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 32	(4,147)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 33	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 34	18,976
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 35	(2,366)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 36	16,610
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 37	52,423
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 38	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 39	52,423
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 40	101,391
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 41	(62,110)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 42	39,281
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 43	(290,048)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 44	(68,623)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 45	(358,671)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 46	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 47	65,941
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 48	65,941
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 49	(290,048)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 50	(2,682)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 51	(292,730)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 52	400,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 53	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 54	400,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 55	400,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 56	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 57	400,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 58	(1,864)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 59	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 60	(1,864)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 61	108,088
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 62	(2,684)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 63	105,406
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 64	69,732
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 65	(12,100)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 66	57,632
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 67	177,820
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 68	(14,782)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 69	163,038
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 70	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 71	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 72	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 73	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 74	986,034
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 75	(462,368)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 76	523,666
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 77	215,385
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 78	(215,385)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 79	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 80	766,675
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 81	1,605,259
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 82	2,371,934
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 83	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 84	919,506
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 85	919,506
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 86	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 87	367,333
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 88	367,333
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 89	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 90	1,007,232
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 91	$ 1,007,232

Schedule of Effect on Condens52

Schedule of Effect on Condensed Consolidated Statements of Changes in Stockholders Deficit (Details)	3 Months Ended
	Sep. 30, 2015USD ($)shares
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 1	$ 38,573,856
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 2	538,043
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 3	39,111,899
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 4	3,636,984
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 5	(1,457,586)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 6	2,179,398
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 7	767,879
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 8	1,962,041
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 9	2,729,920
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 10	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 11	3,174,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 12	3,174,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 13	43,165,743
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 14	4,217,488
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 15	47,383,231
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 16	(40,821,871)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 17	(6,166,108)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 18	(46,987,979)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 19	(2,445,193)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 20	(71,176)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 21	(2,516,369)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 22	(43,267,064)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 23	(6,237,283)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 24	(49,504,347)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 25	(2,355,136)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 26	$ (5,628,065)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 27 | shares	(7,983,201)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 28	$ 118,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 29	118,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 30	68,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 31	68,000
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 32	767,981
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 33	1,962,039
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 34	2,730,020
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 35	3,644,405
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 36	(1,457,585)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 37	2,186,820
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 38	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 39	3,174,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 40	3,174,990
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 41	38
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 42	0
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 43	38
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 44	(23,715)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 45	(23,715)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 46	(2,657,243)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 47	(71,176)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 48	(2,728,419)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 49	(436,680)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 50	(2,019,797)
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 51	$ (2,456,477)